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1. Introduction
1.1. General considerations
The mortality of very low birth weight infants (VLBWI, birth weight less than
1500 g) has fallen in the last 2 decades because of both the improvement of
pre- and perinatal care and the regionalization of care. Pharmacological
therapies have contributed significantly to this improvement by: 1) the use of
surfactant in infant’s suffering from respiratory distress syndrome (Guyer et al.,
2000); and 2) the use of antenatal steroids (Hack et al., 2000). Nevertheless,
there is still a high incidence of both mild and severe neurological abnormalities
in neonatal intensive care unit (NICU) graduates (Vohr et al., 2000). In addition,
no specific therapy has been proven to improve neurodevelopmental outcome.
Postnatal indomethacin for instance, which reduces the incidence of major of
periventricular-intraventricular hemorrhage (PIVH) in tiny prematures, does not
improve outcome at 18 months corrected age (Schmidt et al., 2001).
The long-term primary aim of neonatal care is an intact neurological outcome
(Hack et al., 2000). However, on-line continuous neonatal monitoring
concentrates exclusively on cardio-respiratory variables, while cerebral function
is not taken into account. In this context, electrical brain activity (EBA) as
depicted by an electroencephalogram (EEG) has been one of the most studied
features of cerebral function. However, EEG recording takes place on a serial
basis, if clinically indicated and not as continuous EBA monitoring in newborn
infants.
Continuous EEG evaluation has been introduced in the NICU using the
Cerebral Function Monitor (CFM), a one-channel continuous amplitude-
integrated EEG (aEEG). It was first described by Maynard et al. in 1969 in adult
intensive care and 10 years later, in perinatal care (Maynard et al., 1969a;
Maynard et al., 1979a and 1979b). Currently, the use of aEEG in the NICU can
be seen as an on-line monitor of EBA patterns with prognostic value for term
infants, as well as valuable in monitoring for the presence of seizure activity. To
the contrary, scarce data has been published upon its use in preterm infants.
The limited feasibility of neurological assessment in those infants, who are
usually under the influence of sedative drugs, makes its use relevant in the
NICU. Major difficulties in the interpretation of EEG in preterm newborns are 1)
the inherent physiologic discontinuous trace, and 2) the limited EEG reference
data for the very tiny preterm infants.
The primary motivation for this work is based on the search for early
recognition of impaired neuronal function as depicted by aEEG in preterm
infants. This is aimed to recognize primary causes or the moment of EBA
dysfunction during neonatal intensive care, and eventually to prevent or reduce
permanent cerebral impairment.
Both hypoxemia and hemodynamic instability are a common threat in preterm
infants and are therefore relevant matter for investigation. Hypoxemia or the
lack of an appropriate oxygen supply to tissue is a multifactorial entity, primary
related to impaired and/or immature respiratory condition or to right to left
shunting. Preterm infants are also much more likely to have hemodynamic
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instability, which could additionally affect systemic and eventually cerebral
blood flow and tissue oxygenation. The later of which can permanently impair
neurodevelopmental and neurologic outcome.
In the present work, the impact of hypoxemia, hypotension or both has been
first studied in both the neonatal piglet and in the fetal sheep. This animal
experimentation of on-line monitoring of fetal and neonatal EBA lent the basis
for the further development of the aEEG called the Maastricht Cerebral Monitor
(MCM). MCM was later introduced in the NICU to study the impact of acute
hypoxemia in VLBWI. Parallel to the development of MCM, CFAM3™ (RDM
Consultants Ltd, UK), a 4th generation CFM was developed. Both devices
share some aEEG characteristics and are further described in sections
2.1.2.2.2. and 2.1.2.2.3..
1.2. Aims of the study
1.2.1. To develop a reliable and flexible computerized aEEG for further
clinical and experimental research.
1.2.2. To study the impact of acute hypoxemia, hypotension or both on EBA
in both prenatal and neonatal animal models.
1.2.3. To study the role of acute hypoxemia on EBA as monitored using the
MCM in VLBWI.
1.3 Summary:
The study of on-line continuous neonatal EBA may be clinically relevant in
terms of long-term neurologic development in both preterm and term newborns.
However, it has been rather limited to assess outcome in asphyctic term
infants.
This work describes basic scientific and practical results obtained of the study
on perinatal EBA. It involves experimental and clinical research on EBA in
relation with hypoxemia and hypotension in both fetal and neonatal animals,
and in VLBWI. Particular attention is paid to the development of the aEEG
monitor named the Maastricht Cerebral Monitor (MCM).
This work is a joint venture between the departments of neonatology, child
neurology and clinical neuro-physiology of the University Hospital Maastricht.
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2. Review of the literature
In the following paragraphs, electric brain activity (EBA) features are discussed
in relation to maturational, physiological and pathological changes. Amplitude-
integrated EEG (aEEG) devices, and its applications are further described.
2.1. Electroencephalography in perinatology
2.1.1. The origin and characteristics of electric brain activity
Introduced by Hans Berger in 1929, EEG depicts the summation of
synchronous postsynaptic potentials evoked by the stimulation of radially
oriented pyramidal cells within cortical gyri. These cortical postsynaptic
potentials are synchronized by other nuclei, such as the thalamus (D’Allest and
Andre, 2002). EEG provides electrical assessment of the cerebral cortex and
other deeper structures; however, it does not represent overall brain function.
EEG characteristics comprised:
2.1.1.1. Amplitude
EEG amplitude is expressed in microvolts (µV) and depends on the generation
of potentials and the conductivity of the structures between the brain and scalp.
Mean EEG amplitude is positive correlated with gestational age.
2.1.1.2. Spectral power
EEG contains four broad spectral bands: delta [1- 4 Hz], theta [4-8 Hz], alpha
[8-14 Hz] and beta [14-30 Hz]). Frequencies of less than 7.5 Hz are called slow
waves and those over 13 Hz are usually called fast waves. From a
developmental point of view, slow frequencies, namely delta wave activity, are
the prominent components of “at rest” neonatal EEG’s. This EEG pattern
develops later into a faster and dominant alpha rhythm.
2.1.1.3. Background activity (continuity and discontinuity)
Synaptogenesis, myelination, and biochemical maturation of neurons and glial
cells are the basis for age-dependent electrophysiological changes (Holmes,
1986). EEG has a high correlation with neuropathologic maturational
characteristics (Scher et al., 1987), fetal ultrasound parameters of maturity
(Scher et al., 1994) and with the date of the last maternal menstrual period
(Scher et al., 1995). EEGs of normal preterm infants at term corrected for
gestational age are maturational identical to the EEGs of full-term infants
(Domenech et al., 1989). One of the most impressive characteristics of the very
preterm EEG is its discontinuity. The duration of the interburst intervals (IBIs)
decreases as gestational age (GA) increases (Nunes et al., 1997). IBIs duration
should be less than 40 seconds in infants younger than 30 weeks GA and less
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than 6 seconds in duration in full-term ones (Hahn et al., 1989). Preterm infants
younger than 28-30 wk GA show an EEG pattern termed “tracé discontinu”.
This EEG is discontinuous with IBIs of low voltage or inactivity lasting 8 – 20
sec alternating with higher amplitude and varied spectral power (Mizrahi, 1986).
Another EEG pattern is the “tracé alternant”, which represents the
discontinuous EEG pattern of nonREM sleep in which there are runs of delta
activity alternating with random faster transients. The IBIs show less voltage
attenuation as that seen in tracé discontinu. Tracé alternant is seen in (near-)
term infants by 36-38 wk GA (Mizrahi, 1986). By term GA, the EEG becomes
gradually continuous and is almost totally synchronous at 41-44 wk
conceptional age (Mizrahi, 1986). Synchrony defines the simultaneous EEG
activity in analogous regions of each cerebral hemisphere. Interhemispheric
synchrony increases with GA (Nunes, 1997).
2.1.2. EEG devices
2.1.2.1. Conventional neonatal EEG (EEG)
EEG is a multi-channel recording of EBA on paper or digitally. Within clinical
practice EEG recording is usually short lasting 30 to 60 minutes. EEG is not
immediately available in the NICU and has to be specially requested if clinically
indicated. Furthermore, it is attended full time by an experienced EEG
technician and is reviewed using unaided visual inspection by an expert
neurophysiologist. Because of its multi-channel and unprocessed character,
conventional EEG is the most important non-invasive tool for studying real time
brain activity and the golden standard in the NICU population to date.
2.1.2.2. Amplitude-integrated EEG (aEEG) monitors
2.1.2.2.1.
Cerebral function monitor (CFM™, Lectromed Devices Ltd., UK)
In the late 1960’s, Maynard, Prior and Scott provided the first description of
CFM, a one-channel continuous aEEG, as a method of continuous monitoring
of EBA in three resuscitated adults (Maynard et al. 1969a). This device puts on
paper a processed single-channel EEG recording using a biparietal derivation
covering the triple cerebral arterial boundary zone. This proved to be the least
contaminated by artifacts and allows routine care. The EEG signal is amplified,
filtered and time compressed. Amplitude is plotted in a semilogarithmic microV
scale, which allows the overall trend of EBA to be followed and for very low
voltage EEG amplitude to be identified. The plotted CFM signal appears as a
band, representing the range of voltages of the EBA. The maximal and minimal
amplitude excursions, and the amplitude bandwidth (difference between
maximal and minimal EEG amplitude in a time window) in µV are also
registered. The recording paper speed is 6, 30 or 60 cm/h. The electrical
activity registered with CFM has been shown to be consistent, reliable and
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quite comparable to EEG, and has been further developed in perinatology.
Research on this field has mainly been concentrated on the study of full-term
hypoxic-ischemic encephalopathy (HIE).
aEEG compared to multi-channel EEG:
Bjerre et al., comparing aEEG and EEG in peripartal asphyctic term (n=13)
and preterm infants (n=13), found that aEEG recording matches with that of
multi-channel EEG (Bjerre et al., 1983). Similar findings were reported by
several authors (Hellström-Westas, 1992a; Greisen, 1994; al Naqeeb et al.,
1999; Klebermass et al., 2001). Toet et al. successfully addressed this
controversial issue in (near) term neonates with HIE and/or suspected seizures
(n=36). This prospective study showed a close interobserver agreement for
aEEG and EEG, as well as a good correlation between the two techniques on
both background and ictal activity (Toet et al., 2002).
Practical advantages of aEEG compared to multi-channel EEG:
Two important advantages of aEEG in contrast with conventional EEG when
applied in the NICU are:
1. Compact aEEG traces are relative simple to interpret, allowing for evaluation
of EEG changes by caregivers with no previous EEG experience and
allowing faster review of long periods of recording.
2. Unrestricted access of aEEG recording makes it immediately available at the
cotside.
Limitations of aEEG:
Inherent to the compact format of aEEG, however, is the loss of precision and
fine diagnosis as attained by conventional EEG. For instance, localized ictal
activity restricted to the occipital area, localized delta activity, etc., which required
multiple channels, are not defined by aEEG (Hellstrom-Westas, 2002; Toet et al.,
2002). Nor are short seizures of less than 30 sec detected using aEEG
(Hellström-Westas, 1992a; Murdoch -Eaton et al., 1994; Toet et al., 2002).
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aEEG patterns:
The interpretation of aEEG is based on the recognition of patterns. The most
important patterns in infants are provided here to illustrate their characteristics:
1. Continuous normal aEEG in term infant (fig. # 1).
2. Discontinuous normal aEEG in extreme preterm infant (fig. # 2).
3. Burst-suppression (BS) (fig. # 3).
4. Saw-tooth (fig. # 4): typical pattern of intermittent seizure activity. However,
no saw- tooth pattern but high voltage background activity is depicted when
seizure activity is continuous. If this is the case, simultaneous conventional
EEG is mandatory for diagnosis (Hellstrom-Westas L, 2002).
5. Sleep-wake states: Coherent sleep-wake state patterns using aEEG have
been reported in stable premature infants older than 32-34 wk GA (Viniker et
al., 1984; Hellstrom- Westas et al., 2001; Westrup B et al., 2002).
Fig.1 Continuous normal voltage aEEG measured
measured by MCM in a full-term infant.
Fig. 2 Normal discontinuous aEEG by MCM in a 25
weeks GA infant.
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Fig. 3 Burst-suppression (BS) pattern recorded by
MCM in term HIE.
Fig.4 Saw-tooth pattern of intermittent seizure activity
recorded by MCM in term HIE.
Reported neonatal and perinatal clinical situations studied by aEEG
The first application of aEEG in perinatology was also reported by Maynard et
al., in 15 term fetuses during labor for periods of up to 6.5 h. The authors
studied the influence of maternal medication and fetal distress on causing a
depression on the fetal EBA (Maynard et al., 1979a and 1979b). The work of
Bjerre et al., presented the first characterizations of aEEG patterns in preterm
and term infants (26 to 42 wk GA, n= 28), however this study focused on the
impact of HIE on EBA (data are discussed below) (Bjerre et al., 1983). Since
then, many other authors have discussed and reported the influence of
gestational age on EBA as depicted by aEEG. Viniker et al., studying a
population aged 29.5 to 43 wk GA (n=107), introduced a method of
quantification of aEEG records (Viniker et al., 1984).
The same year, other authors studied 49 normal preterm and full-term infants
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to establish normal parameters of aEEG amplitude at different sleep-wake
states between 28 to 40 wk GA (Verma et al., 1984). More recently, Thornberg
and Thiringer, have further establish normal aEEG patterns at different GA (30
to 37 wk GA, n=19). They showed that a gradual increase in the minimal aEEG
amplitude takes place with increasing GA, resulting in a narrowing of aEEG
bandwidth (Thornberg & Thiringer, 1990). Finally, Hellstrom-Westas et al.
underlined the concept that an increase in continuous aEEG background activity
is positively correlated with GA in preterm infants with GA ranging from 23 to 31
wk (n=31) (Hellstrom-Westas L, 1990).
Hypoxic-ischemic encephalopathy
Bjerre et al. (1983) published the first description of aEEG recording including
both neonates and the impact of perinatal asphyxia in preterm and term infants
aged 26 to 42 wk GA (n=28). Similar aims were reported by Archbald et al.
(1984) in a cohort of 31 infants aged 23 wk to term GA, and by Klebermass et
al. (2001). The resulting conclusion from these studies included the finding that
significant changes in EBA, such as seizure activity, depressed and/ or silent
background activity, characterized severe HIE.
As reported by Thornberg and Ekstrom-Jodal in 1994, a strong association
has been observed between early aEEG patterns and long-term neurological
prognosis in (near) full-term infants. Regardless of the study, persistent
discontinuous electrical activity has the strongest relationship with a poor long-
term outcome up to 6 years of age (Thornberg and Ekstrom-Jodal, 1994; Eken
et al., 1995; Hellstrom-Westas et al., 1995; Thornberg et al., 1995; al Naqeeb et
al., 1999). In addition, severe EBA dysfunction depicted as soon as 3 hours of
birth predicts poor neurological outcome at 1 to 6 years of age (n=68) with a
positive predictive value of 0.78 and a negative predictive value of 0.84 (Toet et
al., 1999). Therefore, aEEG is mostly used as a tool to depict neuronal
dysfunction in asphyctic term infants.
Thornberg et al. considered in their work the analysis of neuron specific
enolase (NSE) in serum and CSF and its correlation with early aEEG patterns
and outcome in post-asphyctic term infants (n=22). They demonstrated that high
CSF-NSE levels and aEEG patterns of BS and/or seizures are associated with a
poor outcome at the age of 18 months (Thornberg et al., 1995).
Recent contributions to the study of EBA in term HIE using aEEG have
focused on the application of neuroprotective interventions. Allopurinol, a
xanthine-oxydase inhibitor given at 40 mg/kg in two dosis within 4 h of birth,
derived EBA and cerebral blood volume stability between 4 and 8 h postnatally
in (near) term infants with severe birth asphyxia (n=11) when compared to
controls (van Bel et al., 1998). In addition, trials on post-asphyctic hypothermia
used aEEG patterns to recognize eligible infants. The authors identified (near)
term infants suffering severe HIE by aEEG and included them for therapeutic
brain or systemic cooling (Azzopardi et al., 2000 [n=16]; Thoresen & Whitelaw,
2000 [n=8]; Gunn et al., 2002 [n=235]).
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Prognosis based on aEEG in non-HIE pathologies
Data by Hellstrom-Westas et al. published in 1990 and 1998 provides an
introductory look at the prognostic value of aEEG in non-HIE patients. They
showed that serial aEEG within the first week of life in preterms infants with
periventricular – intraventricular hemorrhage (PIVH) aged 23 to 32 wk GA (both
studies, n=58) differentiated neurological outcome at the age of 14 months to 11
years.
Determinants of poor neurological outcome amongst survivors were seizures
and suppressed aEEG background and severe PIVH as detected using head
ultrasound.
Seizures
Diagnosis of clinical and silent seizures:
Preterm infants are prone to seizures as opposed to full term infants. In this
context, immaturity of excitatory-inhibitory neuroransmission can increase
seizure initiation and seizure maintenance (D’Allest and Andre, 2002).
Furthermore, in contrast to older infants, newborn infants show electro-clinical
dissociation or silent seizure activity. If this is the case, there is no clinical
correlation with the electric seizure activity. Electro-clinical dissociation occurs in
19 to 79% of infants suffering from neonatal seizures (Clancy et al., 1988;
Weiner et al., 1991). Therefore, continuous EEG monitoring may assess the real
seizure frequency during the neonatal period (Clancy et al., 1988). This is of
particular clinical importance because: 1) Visual inspection of non-paralyzed
infants underrates seizure frequency (Hellstrom-Westas et al., 1985), and
because 2) Antiepileptic drugs (AED) eliminate clinical but not necessarily
electrical seizures (Hellstrom-Westas et al., 1988; Hakeem and Wallace, 1990).
In addition, Hellstrom-Westas showed that seizure activity is extremely frequent
(75%) in infants suffering PIVH and that silent seizures were more frequent
(87%) than those clinically observed (Hellstrom-Westas L, 1990).
Moreover, few studies systematically describe monitoring the effect of
lidocaine and other anticonvulsants on EBA using aEEG (Hellstrom-Westas et
al., 1988; Hellstrom-Westas et al., 1992b).
aEEG changes during surfactant administration
Hellstrom-Westas et al. (1989) presented the first case-report linking the effect
of surfactant administration with depressed EEG in one infant aged 28 wk of
gestation. Later, other authors have tried to clarify this phenomenon:
A significant fall in mean arterial pressure (MAP) with an unchanged cerebral
blood flow (CBF) measured by Near Infrared Spectroscopy (NIRS) or xenon
clearance (133 Xe clearance) was observed in preterm infants (n=34) after a
single dose of 200 mg/kg porcine surfactant. EBA was depressed for 10 to 20
minutes after surfactant administration despite an intact CBF (Skov et al., 1992).
Hellstrom-Westas et al. reported similar findings in preterm infants aged 25 to
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33 wk GA (n=23). This study showed a transient and significant fall in MAP of
9.3 mm Hg after the instillation of porcine surfactant at 2.5 ml/kg (200mg/kg) in
one or two aliquots after deconnecting the ventilator. This effect lasted for less
than 10 minutes and occurred simultaneously with a depressed background
EEG activity. The aEEG pattern, primarily discontinuous at these GA’s, depicted
less burst rate. The authors hypothesized that the EBA changes were related to
hemodynamic instability added to the effect of oxygen free radicals or other not
specified vasoactive substances (Hellstrom-Westas et al., 1992c).
Bell et al., however, found no correlation between a fall in MAP (3.2 mmHg or
10%), plasma hypoxanthine levels and EEG depression after porcine surfactant
therapy. As demonstrated by the same authors as above, CBF as measured by
133 Xe clearance remained unchanged (Skov et al., 1992; Bell et al., 1994).
The issue further explored by Lundstrom & Greisen was whether gradual
hemodynamic changes resulted in less important EBA suppression. Twenty
preterm infants with GA below 34 wk received two or six aliquots of porcine
surfactant (200mg/kg). Reoxygenation was similar in the two groups however
the fall in MAP was less abrupt in those infants receiving six aliquots. The aEEG
depression in terms of less burst rate activity lasting 15 to 20 minutes was
however similar in both groups. The authors concluded that cerebral ischemia is
not the primary cause of EBA changes and suggested that this might be due to
systemic and cerebral vasodilation (Lundstrom & Greisen, 1996).
Taken together, the finding that surfactant administration is able to depress
EBA calls the cerebral ischemia hypothesis into question. The specific
mechanisms remain unknown and deserve further investigation.
Other pathologies studied by aEEG
Periventricular-intraventricular hemorrhage (PIVH):
Greisen (1987) and Klebermass (2001) analyzed the EEG background activity
of preterm infants suffering from PIVH. The authors observed depressed EBA
and seizure activity. Generally speaking, the EBA background was depressed in
infants which showed brain parenchymal pathology. Abnormalities in neonatal
EEG are in general not specific to etiological diagnosis (Holmes and Lombroso,
1993).
Systemic hypotension:
Greisen et al. studied 24 ventilated preterm infants younger than 32 wk GA
with hypotension using aEEG and internal carotid blood flow velocity. After
volume expansion and subsequently normalization of the blood pressure, they
still found a reversible EEG depression (less burst rate) (Greisen et al., 1988).
One year later, the same authors studied the relationship between EBA and
CBF in twenty infants aged 27 to 32 wk GA by combining aEEG and the xenon
clearance technique. They showed that EBA was detectable with CBF as low as
5 ml/100g/min. They further suggested that CBF of less than 8 ml/100g/min
probably indicated impaired brain perfusion (Greisen et al., 1989).
Hellstrom-Westas et al., 1989 deals with the impact of acute hemodynamic
instability as caused by tension pneumothorax in one ventilated term infant.
22
EBA was extremely depressed during the air leak and normalized after pleural
drainage.
Hypoglycemia:
Westas (1989) discussed the implications of hypoglycemia upon EBA. One
septic term patient is described. The authors found reversible EEG seizure and
depressed activity during hypoglycemia. In addition, other authors used aEEG to
ascertain the influence of mild asymptomatic hypoglycemia on EBA in term
infants born to diabetic mothers (n= 12). EBA was not affected (Stenninger et
al., 2001).
Sedation:
In general, Bell et al. studied the effect of sedation on EBA (n=77), and
showed that a continuous drip of phenobarbital and morphine prolonged IBIs. A
single dose of diazepam used as premedication for endotracheal intubation
increased EEG depression. More specifically, the authors argued for the
cautious interpretation of aEEG recording in sedated patients (Bell et al, 1993).
Exchange transfusion:
Thirteen (near) term infants (36.3 ± 1.9 wk GA) were subjected to double-
volume exchange transfusion because of hyperbilirubinemia as caused by
hemolysis, while measuring MAP and aEEG. The authors showed that EEG
amplitude decreased by less than 6% as compared to baseline EEG during a
20-ml blood withdrawal. They concluded however, that the EEG changes were
probably not clinically relevant (Benders et al., 2000).
Neonatal animal experimentation
Near term and newborn lambs:
Shadid et al. studied the effect of allopurinol, indomethacine, deferoxamine
and their combination in newborn lambs aged 4-10 days (n= 35) subjected to
hypoxemia and systemic hypotension (FiO2 0.06 to 0.08 during 30 minutes
followed by exsanguination to induce a MAP of <35 mmHg). The authors
showed a recovery of EBA in all antioxidative therapy groups. Further, there
was no additional effect when the drugs were combined (Shadid et al., 1998).
No significant modification of ECBA as measured by aEEG was observed in
anesthetized newborn lambs aged 4-9 days (n=12) after 10 minutes of
hypoxemia (FiO2 0.08), nor after exsanguination providing a MAP greater than
30 mmHg (van de Bor et al., 1999).
Ten newborn lambs aged 8-10 days were subjected to a double volume
exchange transfusion. Blood was withdrawn in aliquots of 20 ml. The authors
showed a decrease in carotid flow whilst a small and not significant mean EBA
decline was present (Benders et al., 1999).
Thorngren-Jerneck et al. presented the approach of combining postnatal
cerebral glucose metabolism (CMRgl) as measured by PET, with the EBA
recording of aEEG in asphyctic fetuses. Near term fetal lambs (n=8) showed a
reduced brain glucose metabolism and an abnormal EBA 4 hours after 14.5 ±
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4.2 minutes of umbilical cord occlusion and cardiac arrest. MAP, blood gases
and serum glucose were normal. The authors concluded that a global reduction
of CMRgl can be an early indicator of HIE (Thorngren-Jerneck et al., 2001).
Piglets:
Peeters-Scholte et al. described the impact of one-hour of bilateral carotid
occlusion and hypoxia as well as the effect of pharmacological post-HIE
intervention using saline, allopurinol, deferoxamine or 2-iminobiotin in newborn
piglets aged 1 to 3 days (n=43). EBA, cerebral hemodynamics and cerebral
energy status as measured by aEEG, NIRS and phosphorus Magnetic
Resonance Spectroscopy, respectively were significantly less affected in the
intervention groups compared to controls. aEEG was better preserved in the 2-
iminobiotin-treated group (Peeters-Scholte et al., 2002).
Guinea pigs:
Yuan et al. subjected spontaneously breathing guinea pigs aged between 1-4
days (n=36) to a decrease in FiO2 of 0.09 or 0.06 for 10 minutes. According to
this work, EBA depression was more consistent with 0.06 FiO2. In addition, the
authors showed that the animals became apnoeic in response to hypoxia
before the complete suppression of ECBA. This suggested that the respiratory
“switching-off” mechanisms could be activated before severe cortical
depression (Yuan et al., 1995).
2.1.2.2.2.
Cerebral function analysing monitor (CFAM™, RDM Consultants Ltd, UK)
Based on aEEG, the development of CFAM includes improvements in both
device technology and software. In addition to providing amplitude integrated
EEG patterns, CFAM technology introduced EEG spectral power analysis. To
the present day, 3 generations of CFAM devices have been developed and
commercialized. Their specific characteristics are described below:
CFAM 1 (First generation, first report in 1979): a one-channel, chart paper
recording, controlled by a microprocessor. CFAM produces paper traces of the
aEEG, EEG frequency percentage, percentage time-suppression below 1 µV,
scalp muscle activity and electrode impedance. Evoked potentials could be
computed (Maynard, 1979c, Sebel et al., 1983; Maynard & Jenkinson, 1984).
EEG frequency percentage is calculated using a modified zero crossing
technique.
CFAM 2 (Second generation, RDM Consultants Ltd., UK, 1989)
One or two-channel CFAM, DOS based system, digital signal processor for
filtering and Fast Fourier Transform algorithm (FFT), which estimates EEG
background spectral content. Also depicts unprocessed EEG and includes off-
line computerized statistical analysis.
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CFAM 3 (Third generation, RDM Consultants Ltd., UK, 1995)
Up to four-channel CFAM, DOS based CFAM1 system. In addition, CFAM 3
also depicts unprocessed EEG and allows real-time and off-line data analysis.
Differences and advantages of CFAM as compared to aEEG
1. CFAM depicts EEG frequency percentage and evoked potentials.
2. Two or more channel EEG allows the study of EEG symmetry and
synchrony.
3. Digital acquisition and storage.
4. Computerized analysis and post recording evaluation, allows change in the
time base of the recording speed.
Limitations of CFAM
(See aEEG limitations in section 2.1.2.2.1.)
Reported neonatal and pediatric clinical situations studied by CFAM
Since its development, CFAM studies have focussed on the adult population
whilst very few studies have addressed the use of CFAM in the pediatric clinic.
The main paradigm studied is that of pediatric seizures. Three authors have
stressed the importance of studying electric seizures using CFAM (Tasker et al.,
1989a; Tasker et al., 1989b; Crawley et al., 1996).
Murdoch Eaton et al. showed in a retrospective study that asymmetrical EEG
recordings, suppression of background activity or electrical seizures were
predictive of poor outcome at the age of 2 years in an heterogeneous pediatric
population aged 2 weeks to 16 years (median 1.7 years, n=108) (Murdoch
Eaton et al., 2001).
2.1.2.2.3. Maastricht cerebral monitor (MCM)
The effort of our group has focussed on the need for flexibility and simplicity of
EEG acquisition and data interpretation within the NICU. MCM software
responds to this need, as discussed in chapter 3. CFM/CFAM have provided
the basis for the development of the MCM. This technique combines some of
the best features of aEEG and CFAM. Detailed technical considerations are
described in chapter 3 of this thesis (Reulen et al., 1999). In brief, the MCM
characteristics are:
MCM uses the software Poly (Inspektor Research System ®, Amsterdam, NL)
for digital EEG acquisition, data storage and review.
MCM depicts three-channels of EEG electrodes (P3 -Fz; P4 -Fz; P3 -P4) as
unprocessed EEG, EEG amplitude and absolute as well as relative frequency
domain. Epochs of 2 or 3.6-seconds are analysed by the computer yielding EEG
amplitude (bandwidth, minimum and maximum mean), frequency percentages
and absolute powers in the delta, theta, alpha and beta signal frequency range.
MCM also displays the percentage time-suppression and allows real-time and
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post recording change of the time base for registration and analysis. MCM does
however not include evoked potential recording.
Advantages of MCM compared to CFM/CFAM:
In addition to the reliability and practical ease of use of the CFAM software,
MCM includes the following parameters that make its use more flexible:
1. Asymmetry, mean and 90% edge frequency and absolute spectral power
analysis.
2. Off-line replay of the recording.
3. On- and off-line storage and editing of comments.
Reported applications and clinical situations studied by MCM:
MCM’s applications are extensively discussed in chapters 4 to 8 of this thesis.
2.2. Summary:
1. aEEG allows long-term, flexible and reliable EBA recording in the NICU.
2. Currently, aEEG has turned into a reliable prognostic tool for use in
asphyctic term infants and eventually in those who are suitable for
neuroprotective therapies.
3. The study of continuous aEEG both in preterm infants and as a long-term
monitoring tool is limited.
4. aEEG is complementary and inseparably bound with conventional multi-
channel serial EEG.
The following chapters emphasize our experience with perinatal
experimental aEEG monitoring and finally report our experience in VLBWI.
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Summary
Although long-term monitoring of cerebral activity can be important in the
neonatal intensive care, the complexity of multi-channel EEG makes it less
suitable for this purpose. In the past, a cerebral function monitor (CFM) was
developed (Maynard [10]; Prior and Maynard [15]) that analyses EEG. The
output parameter of the CFM is a semi-logarithmic amplitude distribution
resulting from the amplification, bandpass filtering, compression, rectification
and smoothing of the single-channel EEG. Drawbacks of the CFM include its
inflexibility and limited single-channel processing capacity and its lack of
functionality for data storage, review or re-analysis. Modern computers are
powerful enough that a system can be built which does not have these
drawbacks. We have developed such a system: the Maastricht Cerebral
Monitor (MCM). The MCM is a flexible system that not only overcomes the CFM
drawbacks but also provides advanced signal analysis. It was developed with a
software system (Poly) for acquisition, high quality real-time display, on-line
analysis and storage of physiological signals. The MCM processes three EEG
signals in the amplitude and frequency domains. Other parameters provided by
the MCM are asymmetry of absolute frequency powers, %suppression, mean
and 90% spectral edge frequency. Electrode impedance is recorded as a
measure of the quality of the recording.
Key words
EEG, cerebral monitor, CFM, CFAM, MCM, Poly, neonatal, intensive care
1. Introduction
The monitoring of cerebral electrical activity by EEG is especially important
in the neonatal intensive care unit (NICU) (Holmes [9]; Altafullah [1]; Eken [3];
Hellström-Westas [8]). The majority of the newborns treated in the NICU can be
regarded as ‘cerebral-risk’ patients.
Multi-channel EEG recording poses numerous problems for monitoring in
the NICU. First of all, it requires considerable technical skill, time and expertise
to interpret the on-line tracings. Secondly, the bulky equipment may impede
access to the infant, and thirdly, it is difficult to apply a large number of
electrodes to the relatively small area of scalp available on an infant. To
increase the benefits of continuous EEG-monitoring, a system is required that
is automated and gives a rapid on-line analysis and indication of cerebral
function. Several devices are available that meet these demands by using data
reduction techniques (Procaccio [16]; Toner [17]; Thomsen and Prior [19]). All
make it obligatory to sacrifice much of the information contained in the regular
EEG in order to make continuous monitoring possible.
In the past a single-channel cerebral function monitor (CFM) was developed
(Maynard [10]; Prior and Maynard [15]) that output to a low-speed paper
recorder a semi-logarithmic amplitude distribution resulting from the
amplification, bandpass filtering, compression, rectification and smoothing of
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the original single-channel EEG. This monitor gives only a gross indication of
overall cerebral activity, but it has the advantage of providing continuous
cerebral surveillance with minimal interference (Thornberg and Ekström-Jodal
[17]). The analysis provided by the CFM is predominantly in the amplitude
domain. However, the EEG of the early neonate is characterised by transient
bursts of activity of mixed frequency superimposed on a flat background
(Hellström-Westas [6]). With increasing gestational age, the iso-electric
intervals between bursts of activity become shorter and the voltage differences
between bursts and attenuated activity during sleep become smaller
(Thornberg and Thiringer [18]). These facts indicate that frequency analysis is
invaluable in the interpretation of the maturing EEG, something that the CFM
can’t provide. Other major drawbacks of the CFM are its inflexibility, its limited
one-channel processing capacity and its lack of functions supporting data
storage, review and re-analysis. Nowadays a modern system for cerebral
monitoring can overcome these limitations. This paper describes the main
properties of one such newly designed computerised NICU cerebral function
monitor: the Maastricht Cerebral Monitor (MCM).
2. Description of the original CFM
The original cerebral function monitor, the CFM, has been available now for
over 20 years and was originally constructed for use in adult patients. The CFM
provides a filtered, integrated and compressed EEG signal as a single trace
from a pair of parietal electrodes (P3 and P4) (Maynard [10]). These parietal
electrodes were selected for several reasons: parietal EEG amplitude is
relatively large both during wake and sleep, and while this region is sensitive to
minor muscle potential and/or eye-movement disturbances, placement in this
region does not interfere with nursing procedures, it doesn’t lead to pressure
sores, and finally, it covers the area of perfusion by those arteries most
vulnerable to ischaemic brain damage. The output parameter is recorded with a
time compression factor of about 500. The electrode impedance is continuously
measured and written out in order to provide a measure of the technical quality
of the recording. The filtered EEG signal is rectified, smoothed and amplitude-
integrated before it is registered on heat-sensitive paper (slow speeds of 6 or
30 cm/hour) with a semi-logarithmic amplitude scale running from 0 to 100 µV.
This scale makes the CFM more sensitive to activity in the low voltage range
without the need for gain adjustment. The CFM makes long-term monitoring
possible for hours or even days. This is achieved by first filtering the original
EEG signal with an inverse U-shaped bandpass filter which has a maximum at
10 Hz and declines sharply below 2 Hz and above 16 Hz, and then rectifying
and smoothing the instantaneous integrated amplitude with a smoothing time
constant of 0.3 s. The signal processing performed in the CFM is summarised
in the block diagram of Fig.1.
Comparison of the CFM output with the traditional EEG has shown that CFM
can signal significant alterations in the functional state of the brain (Prior &
Maynard [15]; Hellström-Westas [7]; Greisen [5]). A major advantage of the
CFM is that the direct availability of the record makes prompt intervention
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possible in occurrences of seizure activity or other disturbances of brain
function. The interpretation is based mainly on pattern recognition and is
relatively easy to carry out once the limitations of the instrument are understood
(Viniker [21]). The trace appears as a band that can be characterised by width
and mean value. For example, in the case of “burst-suppression” activity, i.e.,
intermittent bursts of activity separated by periods of electrical silence, the
output is a low-level band with a comb-like appearance (see Fig.2). The lower
edge of the band corresponds to the lowest amplitude of the EEG signal and
the width of the band indicates the variations in the minimum and maximum
voltages of the cerebral electrical activity.
Fig. 1. Block diagram of single-channel EEG signal processing
in the original CFM (from Prior and Maynard, 1986).
Fig. 2. Example of a CFM signal as a function of time (amplitude in V).
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2.1. Major drawbacks of the original CFM
The major drawbacks of the original CFM can be summed up as follows:
- montage: the P3-P4 recording reflects instantaneous differences in electric
potentials between the two parietal regions. Hence, in situations with inter-
hemispheric asymmetry, the one-channel CFM could be falsely normal.
Furthermore, a one-channel EEG recording as a marker of cerebral activity is
rather limiting.
- no frequency analysis : the recording contains no information on frequency
content.
- no re-analysis/review : there is no facility to store and to re-analyse the data,
to perform statistical computations on the data or to review the data off-line in
another mode of presentation.
- no signal combination: EEG parameters cannot be combined with other
physiological signals such as heart rate, respiration, SaO2 saturation etc.
2.2. Cerebral function analysing monitor CFAM
More than ten years after the CFM was introduced, its design was modified
and then implemented in a prototyped cerebral function analysing monitor
(CFAM1) (Maynard [11][12]). Initial clinical experiences with the CFAM1 were
reported in 1984 (Maynard and Jenkinson [13]). The CFAM1 (® Health care
developments Ltd, Herts UK) incorporates a 6808 microprocessor, a two-
channel chart recorder and a visual display unit. The CFM trace was modified
and in the CFAM1 it gives 90th percentile, the mean and the tenth percentile of
the weighted amplitude distribution, with minimum and maximum excursions in
every two-second epoch. The CFAM1 incorporates frequency information
including beta, alpha, theta and delta activity as well as the percentage of EEG
suppression. It computes the relative spectral power of the CFM-transformed
EEG signal by means of a modified zero crossing and integration technique.
Separate bands for muscle activity and very low frequencies (VLF) are also
present.
The CFAM2, released in 1993, can compute two-channel evoked potentials
and write two unprocessed EEG signals on a chart recorder. At selected
intervals, chart output can be switched between EEG, CFM and spectral
signals of either channel. The CFAM2 can be interfaced to an external
computer via an RS232C connection.
Very recently a fourth generation CFAM3 (1997) was announced. It provides
four channels of evoked potential computation concurrently with up to four
channels of EEG monitoring compressed in the conventional CFAM
amplitude/frequency distribution format. Data are recorded on the hard disk of a
computer and all modes can be output selectively to the thermal chart recorder.
The monitor can be trained for research purposes to classify patient data into
specific maps, using a neural network system.
Significant improvements were introduced in each of the successive CFAM
systems. These improvements were intended to make them suitable for use in
many applications, such as monitoring during anaesthesia. However, the data
presentation mode, system flexibility and user-friendliness remain rather
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limited.
3. Description of the MCM
Because of the limitations of the CFAM systems, we started the development
of a new cerebral monitor especially designed for neonatal intensive care. The
MCM consists of a two channel EEG-amplifier that is interfaced to a personal
computer. The complete system is built onto a trolley to make it mobile. The
MCM processes the EEG signals in the amplitude and frequency domains. The
major design concepts regarding the processing of the CFM signal have been
adopted from the original CFM (Prior [15]).
3.1. Hardware
The front-end of the MCM consists of an eight-channel optically isolated
referential EEG-amplifier (EEG8) (® Contact Precision Instruments, UK) of
which two analogue output signals (channels 1 and 2) are connected to an A/D-
converter (® DASH1602, Keithly) located within a Pentium-processor-based
personal computer system. For patient safety the computer is powered via a
safety transformer. The MCM remotely controls the EEG8 via the I/O control
lines of the A/D-converter. It can remotely change the amplifier settings
(sensitivity, lowpass and highpass cutoff frequency (-12 dB/octave) and 50-Hz
hum notch filter (50 dB/octave)) and the amplifier mode (calibration, impedance
check, unblock). Unblocking is provided to allow re-centring of the signal
immediately before a measurement, or at any time when the signal has gone
widely out of range, for example, because of a movement artefact. The
bandwidth of the EEG8 is from 0.03 Hz (HP) to 70 Hz (LP). In calibration mode
a 0.5-Hz square-wave calibration signal of fixed amplitude (100 µV) is
generated and read into the MCM.
3.2. Data acquisition
Two analogue EEG signals (P3-Fz and P4-Fz) are digitised with a 12-bit
resolution. According to the theorem of Shannon, the maximum sampling
frequency should be twice the maximum signal frequency, which in this case is
about 30 Hz. However, undistorted display of the EEG signals demands a
higher frequency; a value of 100 Hz was chosen. In the MCM the third EEG
signal (P3-P4) is computed by subtraction of the two digitised input signals ((P3-
Fz)-(P4-Fz)).
3.3. Signal processing
In the MCM, the compressed EEG signal is generated based on the
properties of the original CFM/CFAM (Maynard [10][13]). An asymmetric digital
bandpass FIR filter is applied to the amplified EEG which flattens the frequency
spectrum by giving equal weight to the energy in the signal components
between 2 and 15 Hz (Prior and Maynard [15]). Signals with a frequency below
2 Hz are reduced to minimise the influence of low frequency artefacts such as
movement and/or sweating. High frequency artefacts such as muscle activity
measured by electromyography are reduced. The gain-frequency plot of the
MCM filter is shown in Figure 3 together with the filter characteristic of the CFM.
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There are only minor differences in the gain-frequency characteristics
between 2 and 15 Hz. However, a significant difference exists for frequencies
exceeding 15 Hz: the MCM filter causes an abrupt drop in power, whereas in
the CFM the power in the higher frequency components diminishes gradually
because of the properties of the analogue filter.
Fig. 3. Bode plot: relative gain as a function of frequency
for the original CFM and the MCM.
3.4. Semi-logarithmic amplitude compression
So that both very low amplitude EEG and large signals can be displayed
without the need for extra gain control and/or range switching, the relation
between the input EEG and the compressed output EEG signal has been made
linear up to 5 µV and semi-logarithmic for larger input values. When the EEG
overloads (i.e., signal clipping; EEG amplitude exceeding 200 µV) the CFM
amplitude is written above the vertical y-axis.
3.5. Rectification, peak follower and smoothing
To reduce short-term fluctuations, the semi-logarithmic amplitude-
compressed and rectified signal is smoothed by exponential backwards
weighting with a time constant of 0.5 seconds (Prior and Maynard [15]). Finally,
a so-called peak follower is applied. The output approximates the smooth line
drawn through the peaks of the compressed signal with the DC-component
retained.
40
4. Properties of Poly
The MCM system was developed making use of the physiological analysis
system Poly (® Inspektor Research Systems, Amsterdam), which is a software
system for the acquisition, high quality real-time display, on-line analysis and
storage of physiological signals. It provides a mouse-driven protocol for quickly
setting up, executing and evaluating recordings in particular in an unattended
‘monitoring’ environment. Real-time alarm detection, manual event marking and
review of stored data are all possible during recordings. Figure 4 presents a
schematic of the major functions of Poly.
Poly has its own stack oriented programming language called SPL (Signal
Processing Language). So-called Measurement Configurations (MCs) can be
developed in SPL that describe the signals to be recorded, their calibration,
display, processing, alarm detection and analysis. The signals can be just data
from external devices like A/D converters but they can also be the results of
calculations implemented in SPL code. The program for an MC is split up into
three parts: Pre-SPL, Signal-SPL and Alarm-SPL. The Pre-SPL is used for
variable declarations and signal-independent initialisations. The Alarm-SPL is
used for signal-independent code that, for example, collects results from multiple
signals and generates reports. The Signal-SPL code consists of one or -more
sections, one for each signal in the MC. Each of these sections produces at least
one result, namely the value of the corresponding signal. This value can be
automatically displayed and stored to disk.
Each signal or computed variable is connected to a graph. Various screen
layouts and special graphs can be defined and configured with simple layout
expressions in which original and/or processed signals can be combined. All
interactions of the user with the MCM take place via mouse clicks in the different
screens and selected keyboard input. It is possible to switch quickly from one
pre-defined display configuration screen to another, to add comments and to
pause/continue the storage of original and processed data. All input channels in
the MCM are sampled with a frequency of 100 Hz. The storage rate of the
signals and computed variables is selectable for each signal (up to the maximum
sampling frequency).
Poly provides two ways to review recorded data: (i) Data that have been stored
during acquisition can be reviewed off-line in a paperless EEG mode. (ii) The
original recording or specific parts of it can be marked as a so called ‘playback
file’ and be input to the MCM or some other user-defined Poly program. In this
way the original recording can be replayed as if it were being measured at that
very moment (Scan mode); all computations and signal manipulations can be
carried out again without creating a new recording. Copy & Process mode is
used to create new recordings based on existing ones: they can be used to
merge existing recordings with each other or with real-time data, to extract
interesting parts and to condense information.
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Fig.4. Block diagram of Poly
5. MCM recording procedure
5.1. Calibration
The MCM starts up by triggering the EEG8 amplifier to generate a 0.5-Hz
square-wave calibration signal in both channels. The signals are read into the
system and are automatically quantified, after which the values are stored in a
calibration file. If the automatic evaluation is incorrect, the values can be
adjusted manually.
If the software ‘crashes’ during monitoring, the MCM system must be quickly
restarted. The calibration procedure can be bypassed in that case by retrieving
the data from the calibration file. Upon completion of either the full calibration
procedure or the retrieval from file the MCM enters monitoring mode.
5.2. On-line monitoring
The MCM processes the three EEGs to give several ‘Derived Compressed
Parameters’ (DCPs). The DCPs are: - CFM signal,- absolute and relative
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spectral power in the delta, theta, alpha and beta frequency bands, - absolute
spectral band asymmetry (see section Asymmetry) between P3-Fz and P4-Fz,
mean and spectral edge frequency (90% limit) for P3-Fz and P4-Fz,
- percentage of EEG suppression (see section EEG spectral analysis).
The DCPs are computed for each EEG every 3 seconds and stored on hard
disk together with the original EEG signals (4.5 Mbytes/hour). The DCPs are lso
stored temporarily in internal memory buffers so that during the ongoingrecording
different combinations of original EEG data and DCPs can be presented on the
screen. An example is shown in Figure 5.
The sensitivity and time base of the EEGs can be adjusted in on-line mode, all
DCPs can be reviewed (backward and forward paging), parameter statistics can
be computed and recording comments can be added. The raw EEG data that
has already been stored can only be reviewed in off-line review mode. The time
base for DCP review is 2700 seconds, i.e., 45 minutes (screen resolution 1280 x
1024 pixels; 900 screen pixels; 1 pixel corresponds with 3 seconds). The
minimum and maximum CFM values in every 3-second epoch are calculated and
displayed. By drawing a vertical line between the two values, the original pen-
writing CFM is imitated on the screen. The CFM data are presented on two time
bases, either 45 minutes or 3 hours, allowing backward paging per 15 minutes or
1 hour respectively. It is possible to read out CFM amplitudes at any given
mouse-selectable time. Furthermore, statistics (mean maximum and mean
minimum CFM values; mean EEG amplitude; maximum, minimum, and mean
CFM bandwidths; etc.) can be computed over a user selected time interval and
stored as a recording comment.
5.3. Off-line review
In off-line mode the original EEGs and the DCPs can be reviewed. It is possible
to add/edit comments and, guided by these comments, to select relevant data.
One or more parts of the original recording can be selected and
processed/analysed by a Scan or Copy & Process MC. Results are generally in
the form of automatically generated comments indicating events, report files with
statistics and user defined files with derived data such as frequency spectra etc.
Predefined print macros can be used to select documentation and print
recorded data. The same method of display expressions is used to define the
layout of the printed signals as was used for the recording of the signals.
6. MCM analysis options
6.1. EEG spectral analysis
The digital filters in the MCM (Williams [22]) are all so-called non-recursive Finite
Impulse Response (FIR) filters (Otnes and Enochson [14]), which have stable
properties and no phase shift. In Poly, filtering is done through convolution. Each
digital filter is a combination of a lowpass and a highpass digital FIR filter: the
desired band filter response is described in the frequency domain. This function
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is converted into an impulse response using the inverse Fast Fourier Transform
(FFT). This impulse response consists of 257 coefficients and constitutes the so-
called filter buffer. Poly computes the convolution of the filter buffer with the
current signal buffer. Every sample point in the signal buffer is then shifted one
sample (last out, first in).
For every sample point (10 ms) the absolute value of the filtered signal is
computed for each of the three original EEGs in the different frequency bands
(delta: 1-4 Hz, theta: 4-8 Hz, alpha: 8-14 Hz, and beta: 14-30 Hz). In this way
four band-limited signals are generated per EEG channel. The spectral data of
each channel in the four frequency bands are stored into a 3-second buffer to
facilitate further processing, reduction and presentation of the data. The filtered
signals are then rectified and the area under the curve is computed, giving the
absolute spectral value for each band for each channel. For each band the
relative area with respect to the summed areas of all bands is also computed for
a specific signal and expressed as a percentage between 0 and 100%, resulting
in relative spectral power.
In both on-line and off-line mode it is possible to compute the mean relative
spectral value per band in a user-selected interval as shown in figure 5. Two
other informative parameters, namely the mean frequency and the 90% spectral
edge frequency, are computed based on the relative spectral powers for every 3-
second epoch in each of the four spectral bands. An example is shown in Fig.6.
Because relative EEG frequency bands are not independent of each other, the
absolute power in each band is also computed and can be shown on the screen.
6.2. Asymmetry, mean and spectral edge frequency
Asymmetry is computed so that hemispherical dysfunction and synchrony of
maturation EEG can be studied. Asymmetry (Ai ) is computed in every 3-second
epoch (k) according to
A i (k) = ((R i – L i) / (R i + L i)) x 100% (i = 1,2,3,4) for the four spectral bands (1:
delta, 2: theta, 3: alpha, 4: beta) . R i is the absolute spectral power of the i-th band
of the EEG signal P4-Fz and L i the corresponding value of P3-Fz for a 3-second
epoch.
Finally, asymmetry Ai (k) is smoothed by exponential backwards averaging using
standardised weight factors according to
Ai (k) = 0.5 x Ai (k) + 0.25 x Ai (k-1) + 0.125 x Ai (k-2) + 0.0625 x (Ai (k-3) + Ai (k-
4)).
Further parameters derived from the spectral data are the mean and 90% spectral
edge frequencies.
6.3. Suppression
To provide an indication of the overall amplitude behaviour of the original EEG,
the percentage of the rectified EEG with absolute amplitudes lower than 10 µV is
computed in every 3-second epoch. This is called % suppression.
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6.4. Extra MCM functions
6.4.1 Impedance measurement
To ensure good quality recordings, the electrode impedances must be attended
periodically. The impedance option makes it possible to automatically check the
electrode impedances (I-check) at any pre-set and software selectable moment in
time. Extra checks can be initiated manually. Whenever an I-check is performed
automatically a recording comment is attached to the data file, storing the actual
time and the impedance values for later review.
6.4.2. Reliability
Prevention of system failure, or ‘crashing’, is extremely important for a long-term
monitoring system. The number of crashes is reduced because of a built-in ‘data
wait queue’, the filling grade of which is always displayed. If the system becomes
overloaded, for example, by keyboard or mouse-click initiated time-consuming
actions such as changes in screen display, then the incoming EEG data are
temporarily stored in the queue. If the queue overflows, the system crashes. To
prevent queue overflow, the system switches to a less time-consuming display
when the queue overflow reaches 20% above the queue capacity.
Another important reliability aspect is to prevent system crashes when there is
no more storage capacity on the computer hard disk. In this situation the system
automatically stops storing data and gives a warning, but it continues to display
new data. Finally, apart from some basic user keys, the keyboard is disabled to
minimise the likelihood of unauthorised manipulation of the system.
45
46
7. Discussion
The MCM system was and is being evaluated in experimental and clinical
practice, respectively (Bunt [2]).
Animal experiments performed by our research group showed that isolated severe
systemic hypotension affected neuronal activity as reflected by the MCM. A mean
arterial pressure of 30 mm Hg was the cut-off for cerebral perfusion impairment and
neuronal dysfunction in our piglet model (Bunt[2], Gavilanes[4]). An increase of
relative delta wave power preceded significant changes in EEG amplitude. We
speculate that changes in delta power might offer the possibility to anticipate critical
changes in cerebral electrocortical activity and haemodynamics (Gavilanes[4]).
Clinical application so far shows that the equipment does not obstruct the
functioning of other systems surrounding the neonate. It fulfils the demands set by
the neonatologist and can be applied rapidly by nursing staff. The benefit of the
MCM in our NICU setting is its simplicity and ease of interpretation and the need for
only minimal attendance over prolonged periods of time. However, the MCM
provides a supplementary measure and it cannot replace the conventional EEG.
Consequently, a combination of intermittent EEG and continuous MCM is probably
optimal to monitor the neonatal brain.
Comparison of the MCM with earlier CFAM systems shows that MCM flexibility
and efficiency of data handling and presentation both during on-line recording and
off-line review are superior. User interaction is improved for ease of operation.
MCM (asymmetric) digital filtering has several advantages over the analog
filtering properties of the original CF(A)M systems; it causes an abrupt instead of a
gradual decrease in signal power for signal frequencies exceeding 15 Hz. In this
way the EEG is optimally band limited, reducing the influence of aliasing on
spectral parameters due to signal frequencies above 15 Hz. Furthermore, the
influence of high frequency signals giving rise to artefacts in the EEG is strongly
reduced, in particular electromyographic and /or electrocardiographic signals.
MCM spectral analysis is performed on the original EEG and not on the CFM
signals, and it applies FFT instead of zero crossing, which makes it more reliable.
Finally, not only interdependent relative spectral properties but also absolute
spectral properties are computed.
In the MCM various display configurations are implemented which can be paged
through both during on-line recording and off-line review. The choice for these
types of display was guided by clinical and efficiency arguments. A major design
criterion was to display data time compressed together with a zoom function for
more detail. Similarly display of combined amplitude and spectral parameters to
study their interdependency.
Unlike the CFAM systems, the MCM is not equipped with options for recording
evoked potentials. We did not consider this to be an important feature for cerebral
NICU monitoring.
On-line simultaneous acquisition of other physiological data, such as blood
pressure, heart rate, respiration, eye movements and blood gases may aid in
understanding the causes and effects of changes in the EEG. The need to correlate
these parameters with MCM parameters has increased. For this reason we plan to
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interface the MCM with the output signals of our standard HP-Merlin monitors.
The CFAM3 offers the possibility to collect data banks on the basis of which EEG
can be classified making use of neural network computations. An important aim of
ours is to extend the MCM to include algorithms for the detection and classification
of the different neonatal EEG patterns such as tracé alternant, burst-suppression,
low-voltage EEG and epileptic seizures.
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CHAPTER 4.
EFFECT OF REPETITIVE UMBILICAL CORD OCCLUSIONS
ON NEURONAL BRAIN ACTIVITY MEASURED BY THE
CEREBRAL FUNCTION ANALYZING MONITOR AND
HISTOLOGIC OUTCOME IN IMMATURE FETAL SHEEP
H. Keunen, J.S.H. Vles, J.L.H. Van Reempts, A.W.D.Gavilanes and T.H.M. Hasaart
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Abstract
Objective: To examine the effect of repetitive total umbilical cord occlusions on
electrocortical brain activity as measured by cerebral function analyzing monitoring
(CAFM) and the histologic outcome in immature sheep fetuses.
Study Design: We performed brief repeated total umbilical cord occlusions, two
every 5 minutes, in 12 immature sheep fetuses (at 90 days of gestation, term 147
days) until fetal mean arterial pressure dropped below 50% of baseline value during
two successive occlusions. A pair of electrodes was inserted on the parietal dura for
recording of electrocortical brain activity (ECoG). Off-line ECoG signal processing
consisted of amplitude integrated analysis (CFAM) and spectral analysis. Fetal
blood gas analyses were performed at regular intervals just before subsequent
umbilical cord occlusions. Three days after the occlusion neuronal damage was
evaluated histologically in three regions of the fetal brain.
Results: CFAM amplitide parameters decreased significantly during the first
occlusion and remained so during the entire repetitive occlusion period (analysis of
variance [ANOVA]; P < .05). Spectral analysis of the ECoG signal demonstrated no
changes in the distribution of frequency bands. Progressive acidemia and
hypotension developed with ongoing occlusions. Five fetuses died at the end or
shortly after the entire repetitive occlusion period. No neuronal damage or
macroscopic intraventricular and/or germinal matrix hemorrhage was observed in
the surviving fetuses.
Conclusion: Repetitive umbilical cord occlusions in immature sheep fetuses
resulted in functional, not structural changes of the fetal brain in surviving fetuses.
At this gestational age, amplitude analysis is more sensitive than spectral analysis
of the ECoG signal to functional changes of the compromised fetal brain.
Author Keywords: Sheep; fetus; asphyxia; CFAM; brain
Introduction
Recently, we reported the absence of neuronal damage in immature fetal sheep
after a single period of total umbilical cord occlusion up to 20 minutes.[1] In clinical
practice, asphyxia during labor is often characterized by short repetitive periods of
fetal compromise. The question remains whether neuronal damage can be
observed when immature sheep fetuses are subjected to repetitive periods of
umbilical cord occlusions rather than a single transient occlusion.
Several methods have been used to monitor the effect of asphyxia on the fetal
sheep brain. These methods include the registration of raw electrocorticogram
signals (ECoG), cortical impedance, and sensory and auditory evoked potentials.
Another possible method is the cerebral function analyzing monitor (CFAM).[2] The
CFAM offers a one-channel registration of cerebral activity from two biparietal
electrodes and is represented as a band. The CFAM is a system of amplitude
integrated electroencephalograms which can be used to predict gestational age
and neurologic outcome of the asphyxiated newborn. [3] The use of CFAM as an
on-line monitor might offer the possibility to monitor cortical brain activity during
periods of umbilical cord occlusion.
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In this study we tested the hypothesis that repetitive total umbilical cord occlusions
result in neuronal damage in immature fetal sheep. Furthermore, we introduced the
CFAM in this chronic fetal sheep preparation to evaluate its ability to monitor
periodic changes in electrocortical activity during repetitive periods of fetal
compromise. Therefore, we subjected immature sheep fetuses to asphyxia induced
by repetitive umbilical cord occlusions to examine the neuronal outcome 3 days
after the insult, the changes in electrocortical activity during the occlusions, and
their possible interrelationships.
Materials and methods
Surgery
Twelve immature fetal sheep (gestational age: mean 90.6 days; range 87
¯
93 days)
underwent surgery using sterile techniques under general anesthesia (sodium
thiopentone 1 g/70 kg intravenously for induction, 1% halothane in a 2:1 nitrous
oxide and oxygen mixture for maintenance). We performed a midline abdominal
incision. We incised the uterus and partly exteriorized the fetus to allow access to
the umbilical cord. A reversible cord occluder (Model VO-4; Rhodes Medical
Instruments, Woodland Hills, CA) was placed around the umbilical cord and then
tested for total occlusion volume by infusing sterile saline. We inserted a polyvinyl
catheter (0.5 mm inner diameter, 1.0 mm outer diameter) in the carotid artery and
directed it toward the heart to measure fetal arterial blood pressure (MAP) and
heart rate and allow arterial blood sampling. The dead-volume space of the
catheter was filled with heparin (5000 IU/mL) which remained in situ and was
removed on the day of the experiment. For registration of ECoG a pair of shielded
stainless-steel electrodes was inserted through biparietal drilled burr holes on the
parietal dura. A reference electrode was sewn subcutaneously into the scalp. We
exteriorized all catheters and electrodes through a small incision in the flank of the
ewe. Ewes were housed in individual cages with free access to food and water. The
ewes were allowed a recovery period of at least 3 days after the operation before
experiments were started. Guidelines for care and use of animals, as approved by
the local animal medical ethics committee, were followed.
Measurements
Fetal blood pressure was corrected for amniotic pressure. We derived the fetal
heart rate from the blood pressure waveform. Signals were collected on a personal
computer, using a hemodynamic data acquisition system custom-built by the
Instrumental Department of the University of Maastricht. Beat-by-beat
measurements of fetal heart rate and mean arterial pressure were displayed on-line
on a monitor. We measured fetal blood gas values and pH with an automated
analyzer (AVL 993; AVL Medical Instruments AG, Schaffhausen, Switzerland) and
corrected them for fetal temperature (T = 39.5C). Fetal hemoglobin concentration
(mmol/L) and hemoglobin oxygen saturation (percentage) were measured with a
hemoximeter (OSM2 hemoximeter; Radiometer, Copenhagen, Denmark). Arterial
oxygen content was calculated as follows: arterial oxygen content (mL/dL) = 1.36 ×
hemoglobin concentration (mmol/L) × hemoglobin oxygen saturation (%) × 1.611.[4]
Experiments
We started experiments when sheep were at a mean gestational age of 93.6 days
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(range 90
¯
96). Fetal heart rate and blood pressure were monitored continuously.
We performed baseline fetal arterial blood gas analyses 30 and 5 minutes before
the first umbilical cord occlusion and immediately before every fourth occlusion.
Total umbilical cord occlusion was achieved by infusing sterile saline with the
predetermined occlusion volume into the occluder. The umbilical cord was
repetitively occluded for 2 of every 5 minutes. Repetitive occlusions were
maintained until the fetal MAP decreased below 50% of baseline value during two
successive occlusions. To limit excessive blood sampling, the maximum time
allowed to reach this degree of hypotension during the repetitive occlusion period
was 4 hours.
Off-line ECoG signal processing
Off-line processing of the raw ECoG signal included weighted digital band filtering
between 2 and 15 Hz, rectification, logarithmic amplitude compression, and
smoothing of the signal. For further analysis epochs of the CFAM signal lasting 3.6
seconds were selected. We calculated CFAM parameters (mean amplitude
distribution and bandwidth in microvolts) using the software program Poly
(Inspector Research System BV, Amsterdam, The Netherlands), modified by the
Department of Clinical Neurophysiology, University Hospital Maastricht. Two
epochs of 10 minutes were used to calculate baseline CFAM values. CFAM
parameters during occlusions were obtained at the first and last occlusion, and at
the occlusion halfway the entire repetitive occlusion period (eg, at the 12th
occlusion when a total of 24 occlusions were administered). At every time point one
epoch of 3 minutes before and after an occlusion and an epoch during the 2-minute
occlusion were calculated. In addition, the ECoG of the similar epochs was
subjected to spectral analysis by means of Fourier transformation resulting in a
percent distribution of the raw ECoG signal over the following frequency bands:
delta (1 to 4 Hz), theta (4 to 8 Hz), alpha (8 to 14 Hz), and beta (14 to 30 Hz).
Fixation and histologic evaluation
Three days after the cord occlusion, a second laparotomy of the ewe was
performed under general anesthesia (sodium thiopentone 1 g/70 kg intravenously
for induction, 1% halothane in a 2:1 nitrous oxide and oxygen mixture for
maintenance). The fetal heart was approached by median thoracotomy. We
heparinized the fetus with an injection of 20,000 U heparin into the left cardiac
ventricle. A blunt steel catheter was inserted in the left cardiac ventricle. The right
atrium was opened and both external jugular veins were dissected and cut. Five
hundred milliliters of isotonic and isocolloidal fluid (Haemaccel; Baxter BV, Utrecht,
The Netherlands) was infused in the left ventricle followed by 750 mL Karnovsky's
fixative (2% formaldehyde and 2.5% glutaraldehyde in phosphate buffer 0.1 mol/L,
pH 7.40). After decapitation the skull was opened and the head was submerged
into the same fixative for additional immersion fixation. After 1 day of immersion
fixation we removed the fetal brain from the skull for histologic evaluation.
Vibratome sections (200 µm) were cut from three areas: first, the parasagittal
cortex, defined as the gyrus adjacent to the sagittal sulcus; second, the dorsal gyrus
of the hippocampus; and third, the cerebellum. Sections were postfixed in 2%
osmium tetroxide, buffered with uranyl acetate (0.05 mol/L, pH 7.40), dehydrated in
graded series of ethanol, and routinely imbedded in Epon. Light-microscopic
55
evaluation was performed on 2µm sections stained with Toluidine blue by an
observer (JVR) unaware of the experimental situation. Neuronal damage was
defined as the degree of coagulative cell change per high-power field, graded on a
nine-point scale in which 0 = absence of coagulative changes and 4 = 100% of the
tissue damaged.[1, 5 and 6] Specific interest was directed toward the neuronal cells
in the cortex, the pyramidal neurons in the CA1 and CA2 sector of the
hippocampus, and the Purkinje cells in the cerebellum.
Statistics
Data are presented as mean ± standard error of the mean. We compared blood gas
and acid base status analyses, hemodynamic parameters, CFAM amplitude
parameters, and the results of spectral analysis by analysis of variance (ANOVA).
We compared changes relative to baseline with t tests with Tukey's correction for
multiple comparisons. Repeated measures were used when appropriate. P < .05
was considered.
Results
The experimental group consisted of 12 fetal lambs with a mean gestational age of
93.2 days (range 90
¯
96) and weight of 716 g (range 608
¯
894). The fetuses were
subjected to a total of 34 occlusions (range 21
¯
48). Of 12 fetuses, five died at the
end or shortly after the occlusion period. Table 1 describes the results of the blood
gas and acid-base status analyses at baseline, just before the first, middle, and final
occlusion, and 2 hours after the final occlusion. Repetitive umbilical cord occlusions
resulted in moderate to severe acidosis, mild hypercapnia, and moderate hypoxia.
In the surviving fetuses all parameters returned to baseline values within 2 hours
after the final occlusion.
The results of the fetal MAP and heart rate measurements at similar time points are
depicted in Table 2. Repetitive umbilical cord occlusions resulted in repetitive
periods of bradycardia. During occlusions, fetal MAP demonstrated a biphasic
response, which consisted of an initial increase followed by a subsequent decrease
resulting in severe hypotension during the final occlusions. Likewise, between
occlusions fetal MAP first increased and then decreased to values below but not
significantly different from baseline values. Nonsurviving fetuses failed to recover
after release of the last occlusion. They remained bradycardic and hypotensive until
they died.
The results of the off-line CFAM amplitude and spectral analysis of the ECoG are
depicted in Figure 1 and Figure 2. All CFAM amplitude parameters demonstrated a
significant decrease during the entire repetitive occlusion period compared with
baseline (ANOVA; P < .05). A decrease in all CFAM amplitude parameters except
CFAM width was observed during the first occlusion and remained depressed
throughout the entire repetitive occlusion period. Of the surviving fetuses, all CFAM
amplitude parameters recovered to baseline values at 2 hours after the final
occlusion. Spectral analysis of the ECoG signal demonstrated no differences
between the baseline and entire repetitive occlusion period.
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Macroscopic and microscopic evaluation of brain damage were performed only on
surviving fetuses. Macroscopic inspection showed no evidence for intraventricular-
germinal matrix hemorrhage (IVH-GMH). Good fixation quality was demonstrated by
the absence of residual erythrocytes in open microvessels and the absence of
disseminated cell swelling. Light-microscopic evaluation of the surviving fetuses did
not demonstrate neuronal damage in the parasagittal cortex, hippocampus, and
cerebellum (score for all surviving fetuses = 0).
Table 1.
Time Course of Blood Gas and Acid-Base Status Analysis
Fetal arterial blood samples were taken at baseline, just before the first, middle, and last occlusion
(all fetuses, n = 12), and 2 hours after the entire repetitive occlusion period (surviving fetuses, n = 7).
* P < .05, t test, compared with baseline.
Table 2.
Time Course of Mean Fetal Heart Rate During Baseline and 2 h After the Entire Repetitive Occlusion
Period, and Minimum Fetal Heart Rate During the First, Middle, and Last Occlusion (beats per minute)
Time course of the maximum (MAP max) and minimum (MAP min) fetal mean arterial pressure during
the first, middle, and last occlusion is shown, as well as time course of the fetal mean arterial pressure
during baseline and 2 hours after the entire repetitive occlusion period, and between occlusions after
the first and middle and just before the last occlusion (MAP int) (mmHg). * P < .05, t test, compared with
baseline.
57
Figure 1.
Time course of CFAM (µV, CFAM maximum (closed circles) CFAM minimum (closed diamonds), CFAM
width (closed squares), and CFAM (closed triangles) during baseline (two epochs of 10 minutes), first,
middle, and last occlusion (three epochs: one epoch of 3 minutes before and after, and one epoch
during the occlusion, all fetuses, n = 12), and 2 hours after the entire repetitive occlusion period (one
epoch of 10 minutes, >2 hours, only surviving fetuses, n = 7). ANOVA: P < .05, #P < .05, t test, compared
with baseline, all CFAM parameters. *P < .05, t test, compared with baseline, all CFAM parameters except
CFAM width. Values are mean ± SEM.
Figure 2.
Time course of spectral analysis of the ECoG signal (%, delta band (open circles), theta band (open
triangles), alpha band (open squares), and beta band (open diamonds) during baseline (two epochs
of 10 minutes), first, middle, and last occlusion (three epochs: one epoch of 3 minutes before and after,
and one epoch during the occlusion, all fetuses, n = 12), and 2 hours after the entire repetitive occlusion
period (one epoch of 10 minutes, >2 hours only surviving fetuses, n = 7). ANOVA: P > .05.
58
Discussion
Repetitive umbilical cord occlusions in immature fetal sheep in this experimental
setup resulted in repetitive periods of hypertension and hypotension, bradycardia,
and sustained mixed acidosis. The degree of hypotension was comparable to the
changes in MAP observed in our previous study where immature fetuses were
subjected to a single total umbilical cord occlusion up to 20 minutes.[1] In
concordance with repetitive umbilical cord occlusions in mature fetal lambs,
changes in fetal MAP demonstrated a biphasic response which consisted of an
initial rise in MAP followed by a subsequent decrease resulting in severe
hypotension during the final occlusions. [7] Because arterial blood pressure is the
result of the product of cardiac output times peripheral vascular resistance,
hypotension at the end of the repetitive occlusion period may result in a decrease of
one or both of these parameters. Severe hypoxia and depletion of myocardial
glycogen stores may decrease cardiac output. Furthermore, in fetal lambs a
decrease in total peripheral vascular resistance was observed during severe
asphyxia. [8] Whether a decrease in cardiac output or peripheral vascular
resistance was responsible for the repetitive periods of hypotension observed in this
study remains unsolved.
The absence of neuronal damage and IVH-GMHs agrees with our previous
observations in immature fetal lambs after a single umbilical cord occlusion up to 20
minutes.[1] The degree of hypotension at the end of the final occlusions in this
study was comparable to the changes of MAP observed in the transient total
umbilical cord occlusion. However, acidosis in the single transient occlusion group
was more severe. In part, this could be explained by the timing of the fetal blood
gas analysis, which was performed just before an occlusion in the present study
compared with fetal blood gas analysis at the end of the single umbilical occlusion
period. [1]
Repetitive umbilical cord occlusions in mature sheep fetuses resulted in cerebral
damage ranging from mild selective neuronal loss to focal infarcts in the
parasagittal cortex, thalamus, and cerebellum.[9] This ontogenetic difference in
neuronal damage also was observed in a comparative study in which mature and
immature fetal lambs were subjected to 10 minutes' total umbilical cord occlusion.
[10] Considering the mortality rate in the present study, fetal demise probably
occurred before neuronal damage could develop. However, histologic analysis was
not performed on nonsurviving fetuses for obvious reasons of postmortem changes.
Several factors may be involved in the apparent resistance to neuronal damage of
the immature brain after asphyxia. The immature brain has small and less branched
neurons with fewer synapses and therefore low basal energy demands.
Consequently, immature fetal sheep have a low cerebral metabolism. [11] In
combination with preservation of cerebral circulation, energy metabolism can be
maintained for a long period during asphyxia. [12] Brain damage may be dependent
on mechanisms other than a lower metabolic rate. In vitro studies in hippocampal
slices demonstrated lower postischemic inhibition of protein synthesis during
ischemic circumstances in slices of immature fetal guinee pigs compared with
mature fetuses. [13] These postischemic disturbances in protein synthesis reflect
the ontogenic changes in vulnerability of the brain. Likewise, ontogenic factors
regarding both excitatory and inhibitory neurotransmitters may have a profound
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effect on the age related susceptibility to hypoxic-ischemic brain injury. [14, 15 and
16]
Although asphyxia and arterial pressure fluctuations were present, IVH-GMHs
were absent. So far, one study succeeded in producing IVH-GMHs in fetal lambs,
although under acute experimental circumstances.[17] However, several studies
failed to demonstrate similar results in chronic fetal sheep preparations. Intact
cerebral autoregulation was described in immature fetal lambs. [18] It is known that
asphyxia can abolish the protective mechanism of autoregulation. [19] Likely, in the
present study hypertensive periods during the first occlusions were not coincidental
with severe asphyxia, whereas hypotension during the final occlusions was not
severe enough to decrease below the lower limit of cerebral vascular
autoregulation.
To date, this is the first report on the use of CFAM in the chronic fetal sheep
preparation. As a simplified one-channel electroencephalogram registration the
CFAM allows noninvasive long-term recording of cortical activity and similtaneous
rejection of artifacts. At present it is used in neonatal intensive care units for the
monitoring of seizures. Furthermore, it is suggested that CFAM can be used as a
prognostic tool after severe peripartal asphyxia.[3, 20 and 21] Currently, a newly
designed computerized cerebral function monitor is in use at our neonatal intensive
care unit. [22]
Fetal CFAM amplitude parameters decreased during the repetitive occlusion
period. However, this decrease already occurred during the first occlusion and
remained so throughout the entire repetitive occlusion period. Evidently, an
umbilical occlusion of 2 minutes resulted in an impairment of cortical activity, which
remained depressed throughout the following 3-minute recovery period and
subsequent occlusions. No further decrease in CFAM amplitude parameters was
observed during the time course of repetitive cord occlusions. At 2 hours after the
final occlusion, CFAM amplitude parameters recovered to baseline recordings in
the surviving fetuses.
Evidence of seizure activity, periodic increases in CFAM amplitude parameters
and fetal MAP, was not observed in the recovery period. The rapid decrease in
ECoG activity also was observed in intermittent umbilical cord occlusions in mature
fetal lambs.[9] However, in that study epileptiform ECoG changes were observed in
the recovery period which were coincidental with subsequent neuronal damage in
the parasagital cortex. The rapid decrease in CFAM amplitude parameters is not in
concert with previous observations in an acute experimental setup in newborn
piglets. [23] In that study, a decrease in CFAM amplitude parameters was observed
only when the piglets were subjected to isolated hypovolemic hypotension or a
combination of hypotension and hypoxemia. Isolated hypoxemia did not result in a
decrease of the CFAM amplitude parameters. In the present study, early occlusions
may result in hypoxemia, not hypotension. Furthermore, final occlusions resulted in
a combination of hypoxemia and hypotension. Therefore, we expected a gradual
decrease in CFAM amplitude parameters toward the final occlusions in the present
investigation. Apparently, repetitive occlusions did result in impairment of neuronal
activity based on hypoxemia in early occlusions and a combination of hypoxemia
and hypotension during final occlusions. Spectral analysis demonstrated no shifts in
the distribution of the frequency bands. In a severely compromised brain, a shift to
lower frequencies might be expected. Consequently, the insults implied in this study
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were not severe enough to change electrocortical brain activity in this way. On the
other hand, electrocortical activity alters as a function of gestational age. [24] A
transition from disorganized to cyclic electrocortical activity occurs at a gestational
age of approximately 115
¯
120 days. The maturational changes consist primarily of a
shift of the distribution of frequency bands from the lower delta to a higher
frequency band beta. Therefore, a shift toward lower frequencies bands during
asphyxia might not have been detectable as a result of the already predominant
lower frequencies in the electrocorticogram of the immature fetuses in the present
study.
In conclusion, repetitive umbilical cord occlusion resulted in asphyxia and ultimately
in repetitive periods of hypotension. However, we did not observe neuronal
damage. CFAM in the fetal preparation is feasible. CFAM amplitude parameters
decreased during the first occlusions and remained so throughout the entire
repetitive occlusion period. On the other hand, spectral analysis of the EcoG signal
did not demonstrate any changes during the entire repetitive occlusion period.
Therefore, in the present study, functional changes in the fetal brain were amplitude
rather than frequency related. Further investigations are warranted to study the
relationship between CFAM amplitude parameters and hemodynamic and histologic
changes during and after fetal compromise at various gestational ages.
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CHAPTER 5.
THE INFLUENCE OF ACUTE HYPOXEMIA AND
HYPOVOLEMIC HYPOTENSION ON NEURONAL BRAIN
ACTIVITY MEASURED BY THE CEREBRAL FUNCTION
MONITOR IN NEWBORN PIGLETS
J.E.H.Bunt, A.W.D.Gavilanes, J.P.H.Reulen, C.E.Blanco and J.S.H. Vles
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Abstract
Little is known about the cerebral electrical respons to short periods of
hypoxemia, hypotension and their combination. These conditions occur frequently
in critically ill newborn infants; their cerebral electrical activity can be registrated
easily with the Cerebral Function Monitor (CFM). Therefore we recorded on-line
cortical electrical activity during hypoxemia and hypotension in 11 newborn piglets
aged 13-18 days. Hypoxemia was induced by reducing inspired oxygen fraction.
Hypotension was induced by withdrawal of blood. The experimental groups were:
Group I: arterial oxygen saturation (SaO2) 45-85%, group II: SaO2 < 45%, group III:
mean arterial pressure (MAP) 50-75 mmHg , group IV: MAP < 50 mmHg, group V:
SaO2 < 85% and MAP 50-75 mmHg and group VI: SaO2 < 85% and MAP <50
mmHg.
CFM registrated normal cortical electrical activity during periods of moderate or
severe hypoxemia (group I and II) and during isolated moderate hypotension (group
III). The cortical activity decreased significantly due to severe hypotension alone
(group IV) and combined hypotension and hypoxemia (group V and VI).
Hypotension has a more potent effect on cortical electrical activity than
hypoxemia in the newborn piglet. Cerebral electrical activity does not change during
severe hypoxemia and moderate hypotension possibly due to cerebral flow
regulation. CFM recorded decreased cerebral electrical activity during severe
hypotension and hypotension with hypoxemia. CFM could provide invaluable data
in severe ill newborns.
Abbreviations
CFM, cerebral function monitor
SaO2, arterial oxygen saturation
MAP, mean arterial pressure
QAo, aorta blood flow
CBF, cerebral blood flow
Introduction
Continuous monitoring of cardiac and respiratory rate, arterial oxygen saturation
and invasive arterial blood pressure are part of modern intensive care routine.
However cortical brain activity, which is supposed to be the main determinant of
long term morbidity, is not routinely monitored because continuous use of conventi-
onal multichannel electroencephalography is technically complicated in the
intensive care unit and difficult to interpret.
In the last decade, a simplified form of continuous EEG recording know as
Cerebral Function Monitor has been developed for the use in neonates (19,25). The
CFM gives a one channel registration of cerebral activity from two biparietal
electrodes and it is presented as a band. CFM was first introduced by Maynard et
al. (17) and has been used in the adult mainly during cardiac surgery, monitoring of
anaesthesia, anticonvulsant therapy and during intensive care (1,6,18). CFM
patterns recorded in neonates are related to postconceptional age, behavioural
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states, seizures, hypoxic-ischaemic encephalopathy and hypoglycemia
(11,12,13,25,26). These studies considered CFM representative of brain function
and these authors described the normal patterns from the different age groups.
However, few neonatal animal experiments or clinical studies have focused on the
study of the short-term impact of hypoxemia and hypotension on neuronal brain
activity recorded continuously by CFM. Newborn infants requiring intensive care
management often present periods of hypoxia and hypotension affecting regional
blood flows and compromising oxygen delivery. These events increase the risk of
damaging the developing human central nervous system, resulting in permanent
sequelae. Brain electrical function ceases at a higher level of cerebral oxygen
delivery than the level associated with hypoxic-ischemic brain injury (3). So the use
of CFM as an on line monitor might offer the possibility to detect critical changes in
cortical activity and help to establish a proper direction of therapy in severely ill
newborns.
The aim of this work was to determine the effects of hypoxemia, hypotension and
the combination of both on cortical electrical activity measured by CFM in the
newborn piglet.
Materials and methods
Eleven newborn piglets aged between 13 to 18 days and weighing 3.2 to 5.0 kg
were used in this study. Surgery was performed under general anaesthesia,
induced by using a mask with halothane 2% and later continued with pentobarbital
i.v. (4 mg/kg/hr) and pancuronium i.v. (0.05 mg/kg/hr) in dextrose 10% in water (6
ml/hr) administered through a peripheral vein in the ear, and later through a femoral
vein. Tracheostomy was performed, and an endotracheal tube 5.0 (ID mm) was
inserted. The piglets were mechanically ventilated with a FiO2 of 0.21 (using an
O2/N2 mixture), frequency of 40/min, inspiratory gas flow 10 L/min, PEEP of 5 cm
H2O and peak inspiratory pressure adjusted to achieve a PaCO2 of 4-6 kPa. A 4 Fr
fiber optic catheter (Oximetrix System, Abbott Laboratories, North Chicago, IL,
USA) was placed in the femoral artery and the tip was advanced into the abdominal
aorta for continuous registration of arterial oxygen saturation and arterial blood
pressure. A 5 Fr catheter was placed in the femoral vein for continuous
administration of fluids, anesthesia and for withdrawal of blood to induce
hypotension.
A left intercostal (5th-6th) thoracotomy was performed to place a 6 mm precali-
brated ultrasonic transit time flow transducer around the aorta (Transonic Systems
Inc., Ithaca NY 14850, USA), for continuous measurements of cardiac output. ECG
electrodes were placed to monitor the heart rate continuously. Rectal temperature
was maintained at 37oC using a heating mattress.
Three silver-plated isolated needle electrodes were inserted into the subcutis (two
biparietal: P3 and P4; one frontal: F0, according to the 10 - 20 system of electrode
placement, impedance: < 2 K Ohm) and connected to the CFM.
Arterial samples (0.2 ml) were obtained every 10 minutes for measurement of
blood gases and pH (AVL, radiometer, Copenhagen, Denmark) corrected for body
temperature. Hemoglobin saturation was measured continuously with the fiber optic
catheter, calibrated in vivo by using an hemoximeter (OSM2 hemoximeter, radio-
meter, Copenhagen, Denmark). Aortic blood flow (QAo), mean intra-arterial blood
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pressure (MAP) and heart rate values were sampled, digitalized and displayed
every 10 seconds using a hemodynamic acquisition system (HDAS) developed at
the University of Limburg. The study protocol was approved by the Medical Ethics
Committee of the University of Limburg.
Experiments
The experiment consisted of four phases of hypoxemia and one phase of
hypovolemic hypotension for each piglet. Two piglets were exposed to three phases
of hypoxemia instead of four. Each experimental phase lasted 15 minutes and was
followed by a recovery phase of 45 minutes. Mean arterial blood pressure during
baseline recordings varied between 75 and 90 mmHg.
Systemic hypotension was defined as a MAP below 75 mm Hg and was induced
by a stepwise withdrawal of blood in total 30-50 ml/kg body weight from the venous
or arterial catheter over a period of 30 minutes. Two levels of systemic hypotension
were obtained: moderate systemic hypotension, MAP 50-75 mmHg (group III, n=4)
and severe systemic hypotension, MAP < 50 mm Hg (group IV, n=7). Recovery of
hypotension was obtained by reinfusion of the volume of blood previously
withdrawn.
Hypoxemia was defined as a SaO2 below 85% and it was induced by a stepwise
reduction of FiO2 from 0.21 to 0.10. The SaO2 obtained at FiO2 0.10 differed
between experiments and animals and it defined the allocation to an experimental
group. After 15 minutes FiO2 was increased to 0.21 (recovery). From a total of 42
hypoxemia experiments, 17 episodes corresponded to isolated hypoxemia. Two
levels of isolated hypoxemia were obtained: SaO2 45-85% (group I, n=12) and SaO2
< 45% (group II, n=5). Furthermore, different levels of hypotension during hy-
poxemia were randomly present in 25 hypoxemia experiments: This combination
was grouped as follows; SaO2 < 85%, MAP 50-75 mmHg (group V, n=16) and SaO2
< 85%, MAP <50 mmHg (group VI, n=9). Blood gases and pH abnormalities were
corrected when necessary using sodium bicarbonate or adjusting mechanical
ventilation. The experiment was ended by an overdose of pentobarbital.
Calculations and data analysis
Sequential processing of the single channel EEG included: weighted
digital band filtering between 2 and 15 Hz, rectification, logarithmic
amplitude compression and smoothing of the signal. For further analysis
epochs of the CFM-signal lasting 3.6 seconds were selected. For each
epoch a vertical line was drawn between the minimum and the maximum
EEG - signal value. CFM recording was displayed on a computer screen
and stored on digital audio tape. Epochs of 10 minutes of baseline CFM
parameters (maximal, minimal and mean amplitude distribution and
bandwidth in microvolts) were calculated by the computer using the
software program Poly (Inspektor Research Systems BV., Amsterdam
The Netherlands) modified by the department of Clinical Neurophysiology,
University of Limburg. The CFM and hemodynamic parameters (QAo, blood
pressure and HR) during experimental conditions were expressed as a percentage
of baseline values. PCO2 and pH were expressed in absolute values. Mean and
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standard deviations of the percentages and absolute values in the different
experimental groups were calculated, and statistically analyzed using the Wilcoxon
matched pairs signed rank test. Statistical significance was considered at p < 0.05.
Results
In the 11 newborn piglets 53 CFM epochs of 10 minutes were analyzed.
The tabel summarizes CFM, hemodynamic and blood gases parameters measured
during the six different experimental situations: hypoxia (group I and II) ,
hypotension (group III and IV) and the combination of both (group V and VI).
During the two different levels of hypoxemia, group I: SaO2 45 to 85% (67±
13.4%, mean ± SD, n=12) and group II: SaO2 < 45% (28.4 ± 9.3 %, n=5), the
obtained CFM and hemodynamic parameters were not different from baseline
recordings (fig.1), except for a significant increase in heart rate in group II.
During moderate systemic hypotension in group III: MAP 50 to 75 mm Hg (59.3 ±
7.8 mmHg, n=4) no difference in CFM and hemodynamic parameters could be ob-
served compared to the baseline registration.
Fig.1 Baseline cortical activity during normoxemia and normotension
recorded by CFM in a 15-days-old newborn piglet.
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However, during severe systemic hypotension (group IV: MAP 35.1±13.5 mmHg, n=7),
hypoxemia with moderate hypotension (group V: SaO2 43.2 ± 24.2 % with MAP 62 ± 10.3
mmHg, n=16) and during hypoxemia with severe hypotension (group VI: SaO2 31.4 ± 15.4
% with MAP 38.4 ± 8.4 mmHg, n=9), CFM parameters changed considerably compared to
baseline values (fig.2). A significant decrease of all CFM parameters was observed in
groups IV, V and VI (table). Aorta flow decreased during periods with severe hypotension, -
during moderate hypotension aorta flow did decrease but not significantly.
Fig.2.Cortical activity recorded with CFM during periods of provoked
systemic hypotension and recovery. Note the immediate effect
of hypotension and recovery in the amplitude of CFM recording.
(MAP:mean arterial pressure).
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Discussion
The aim of this work was to study the influence of controlled hypoxemia and
hypotension on cerebral cortical activity of the piglet measured by CFM. Our results
showed that 15 minutes of isolated moderate or severe hypoxemia or moderate
hypotension did not influence CFM patterns, whereas significant changes were
obtained when severe isolated hypotension occured or when any degree of
hypotension was combined with hypoxemia.
In our experiments, sodium pentobarbital was used as part of anesthesia and it is
suggested in the literature that it could offer some neuroprotective effects, reducing
CBF and cerebral metabolic rate (10). However, all animals received the same
anesthetic, which makes all results comparable.
CFM is a simplified one channel EEG registration. The CFM trace gives the limits of
the rectified amplitude distribution and is presented as a band. CFM provides a
continuous picture of brain activity expressed in microvolts during different
circumstances.
Compared with the conventional EEG, CFM allows long-term recording and on-line
analysis with the additional advantage of simultaneous rejection of artifacts. CFM
has already been introduced in neonatal intensive care units for the diagnosis of
(sub)clinical seizures. It has been reported that CFM correlates well to the con-
ventional multichannel EEG evaluation of cortical neuronal activity in neonates,
except for the recognition of very short seizure patterns (14,21). Moreover, the
presence of recognizable CFM patterns could be useful as a long-term prognostic
tool in case of severe peripartal asphyxia in full term infants (2,4,16,27). However
this method of continuous measurement of neuronal electrical activity has not yet
been proven to be useful in acutely ill newborn infants. For this aim we planned
experiments in piglets to reproduce common clinical situations in the neonatal
period like hypoxemia, hypotension or the combination of both. Moreover, the brain
of a one-week-old piglet is considered to be similar to this of the term human
newborn infant with regard to the degree of maturation (20).
In our experiments, piglet cortical neuronal function registered with CFM re-
mained unaffected despite periods of moderate or severe global hypoxemia. The
only isolated factor, which affected cortical neuronal function, was severe
hypovolemic arterial hypotension (group IV).
Combined hypotension and hypoxemia also affected cerebral function of the piglet
(group V and VI), in this experimental situation systemic hypotension did not have
to decrease as much as in group IV to produce an effect on the CFM parameters.
These observations offer two important points for discussion: one is the lack of
effect of hypoxemia regardless its severity, the other the relationship of neuronal
activity and hypotension.
Alveolar hypoxemia is a very common procedure used in physiology
to challenge control systems, receptors and even cellular behavior. This procedure
is based on the decrease in the oxygen tension in the alveoli and arterial blood, and
the decrease in the hemoglobin saturation, all this leading to a decrease in oxygen
content. Based upon this reasoning it could be proposed that the oxygen delivery to
all body tissues would decrease equally and in direct proportion to the decrease in
oxygen content. This is not correct since there are compensatory general
71
mechanisms, which maintain and redistribute the blood flow to vital organs like
heart and brain. This is the case of the brain, which receives an increase in blood
flow to maintain an adequate oxygen delivery during hypoxemia (24). In summary, a
decrease in FiO2 and in oxygen content does not necessarily produce changes at
neuronal level, since as we previously discussed it can be compensated. The only
way to know the real neuronal oxygenation status would be to measure oxygen
tension intracellulaly. This will allow us to compare electrical activity with
oxygenation status. The fact that we did not see changes in the CFM parameters
could suggest that neuronal oxygenation was sufficient. Periods of isolated
hypoxemia lasting 15 minutes seemed to be compensated through autoregulation.
In this study the episodes of hypoxemia lasted for 15 minutes. This is
shorter than in other studies where decrease in electrical function and neuro-
cellular changes were seen after longer periods of hypoxemia (5,22). However,
repetitive cycles of hypoxemia and reperfusion could cause a more severe energy
failure. Furthermore, multiple ischemic insults in perinatal animal experiments have
shown to produce striatal damage when compared to single insults which induce
primarily cortical and hippocampal damage (9).
The second point of discussion is the association between systemic blood
pressure and neuronal activity. Severe systemic hypotension or the combination of
hypotension and hypoxemia caused very significant changes in all CFM parameters
but were specially noticed in the baseline power of the electrical activity. These
changes must have been produced by a decrease in CBF to critical levels which
compromized oxygen delivery to the brain. The regulation of the cerebral perfusion
is highly complex and ultimately involves cerebral vascular resistance, systemic
blood pressure and cardiac output. CBF during hemorrhagic hypotension in
newborn piglets is well maintained by cerebral vascular vasodilation with MAP as
low as 35 mmHg (7, 28).
In our experiments the cardiac output was affected in two different ways. On the
one hand we induced systemic hypotension through exsanguination of more than
30 % of the circulating blood volume causing hypovolemic hypotension (groups III
and IV). We believe that no anemic hypoxia took place as an additional factor, due
to the acute character of the hypovolemia. On the other hand systemic hypotension
was present in 60 % of the global hypoxemia experiments, probably due to
hypoxemic myocardial failure.
As shown in group IV and VI severe hypotension with and without hypoxemia
caused a decrease in cardiac output (table), possibly affecting the cerebral
perfusion and secondarily predisposing to cerebral corticoelectrical dysfunction
measured by CFM. When moderate hypotension was combined with hypoxemia
(group V) QAo remained unchanged compared to baseline, nevertheless this
combined insult produced changes in neuronal activity most probably due to an
impairment of CBF autoregulation. From our experiments we can hypothezise that
arterial blood pressure is the most important single variable which can affect
cerebral cortical function. This was partially suggested by Hellström-Westas et al.
who reported a significant short decrease in cerebral cortical activity in preterm
infants due to systemic hypotension after surfactant therapy (15).
The fact that neuronal activity recorded by CFM decreased only as a result of
substantial hemodynamic changes and not during isolated hypoxemia suggests that
the adaptative mechanisms to protect the brain offer a reasonable safety range.
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This is supported by observations where electrocortical silence is present only after
a 60% reduction of CBF (8).
In conclusion, cortical electrical activity in piglets recorded with CFM
is decreased in the presence of severe hypotension or hypotension associated with
hypoxemia. Moderate hypotension alone and isolated
hypoxemia of 15 minutes do not influence the cerebral cortical func-
tion of the piglet recorded by CFM. Systemic hypotension can affect neuronal
activity, as measured by CFM, and its correction is essential in sick neonates who
are at risk of hypoxemia due to a compromised respiratory status.
Continuous monitoring of cerebral cortical function using CFM is simple, non-
invasive and is sensitive to acute and important changes in brain perfusion. This
method could provide invaluable data when monitoring cerebral cortical activity in
severely ill newborns.
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Abstract
Objective: To investigate the relationships between systemic and cerebral
haemodynamics and oxygenation, and electroencephalogram (EEG) amplitude and
frequency analysis studied by the cerebral function analysing monitor (CFAM)
during progressive hypovolemic hypotension.
Methods: Six piglets of one week of age, weighing 1.9 to 3.4 kg were mechanically
ventilated under 1 to 1.5 % halothane anaesthesia. After a one hour stabilization,
blood was withdrawn in aliquots of 10 ml/kg over 15 minutes up to a total of 40 to
60 ml/kg. Arterial oxygenation was maintained at normal levels. Thereafter, the total
blood volume previously withdrawn, was reinfused. Changes in near infrared
spectroscopy (NIRS) parameters [cerebral oxidized cytochrome aa3 (Cytaa3),
cerebral blood volume (CBV) or total haemoglobin (tHb: oxy- +
deoxyhaemoglobin)], carotid blood flow (Qcar), maximal EEG amplitude and EEG
frequency percentages were analysed continuously.
Results: The EEG amplitude remained stable until the mean arterial blood
pressure (MAP), Qcar and tHb dropped below 30 mmHg (41% of baseline), 20
ml/min (33% of baseline) and 82 % of baseline respectively. Delta (δ) wave
frequency percentage of the CFAM increased significantly at MAP below 30 mmHg.
EEG amplitude remained depressed after blood reinfusion and haemodynamic
recovery. Cytaa3 changes were not statistically significant, reflecting sufficient
neuronal oxygenation.
Conclusion: Our results show that electrocortical function is affected only by
profound systemic hypotension. This occurred at a higher level of cerebral oxygen
delivery than the level associated with neuronal hypoxia and secondary cell
damage.
Key words
Cerebral Function Analysing Monitor - Near Infrared Spectroscopy - Hypoxic-
Ischemic Encephalopathy - Piglet – Newborn
Abbreviations
CFM : cerebral function monitor
CFAM : cerebral function analysing monitor
CBF : cerebral blood flow
CBV : cerebral blood volume
Cytaa3 : oxidized cytochrome aa3
deoxy-Hb : deoxyhaemoglobin
ECBA : electrocortical brain activity
MAP : mean arterial blood pressure
NIRS : near infrared spectroscopy
oxy-Hb : oxyhaemoglobin
Qcar : carotid blood flow
QEEG : quantitative electroencephalogram
tHb : oxy- + deoxyhaemoglobin
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Introduction
The changes in neuronal function due to compromised oxygen delivery, medication,
metabolic states or traumatic injury is accompanied by changes in electrocortical
brain activity and cerebral haemodynamics (Volpe, 1995; Wauquier, 1993;
Siebenthal and Casaer, 1992). The monitoring of these parameters is a useful tool
to detect compromised neuronal function (Connell et al., 1988; Hellström-Westas et
al., 1991; Tsuji M et al.,1995). However, the techniques developed for on-line
monitoring used in the neonatal intensive care unit (NICU) are mainly directed to
systemic haemodynamic and respiratory variables.
The original cerebral function monitor (CFM) is an asymmetrical filtered, amplitude
integrated quantitative EEG (QEEG) (Maynard et al., 1969). Contrary to the
monitoring of EEG, CFM does not require a skilled technician nor a considerable
EEG expertise for its interpretation. CFM was primarily developed and used in adult
intensive care, cardiac surgery and anaesthesia and it was later introduced in the
care of neonates (Verma et al., 1984). CFM patterns have been described for
different gestational ages, sleep-wake states, seizures, hypoglycaemia and to
evaluate the effect of anticonvulsive treatment. Furthermore, CFM has been
claimed to have a high prognostic value after birth asphyxia in full-term neonates
(Eken et al., 1995; Hellström-Westas et al., 1995a,Thornberg and Ekström-Jodal,
1994). Additionally, CFAM analyses the EEG frequency content (Maynard, 1979).
Available studies have been focussed on the description of clinical and
experimental changes in EEG amplitude registered by CFM in adults and newborns
(Prior et al., 1971; Thoresen et al.,1995; Thornberg and Thiringer, 1990; Bunt et al.,
1996). Less attention has been given to the EEG frequency content.
NIRS is a noninvasive optical technique for assessing circulation and oxygenation
(Siebenthal and Casaer, 1992). This method allows measurement of changes in
cerebral oxyhaemoglobin (oxy-Hb), deoxyhaemoglobin (deoxy-Hb), total Hb (tHb)
and in the level of Cytaa3. Changes in concentration of tHb will reflect changes in
CBV (Tsuji et al., 1995; Bucher et al., 1994). Cytaa3 is the terminal receptor for
oxygen of the mitochondrial electron transport chain. Recent data support the use
of NIRS to determine cerebral haemodynamics and cellular respiration (Tsuji et al.,
1995).
The aim of this work was to study the effect of controlled changes in cerebral
oxygen delivery on cortical neuronal function as monitored by CFAM. This
information will help to understand the value of continuous monitoring of cerebral
electrical activity in seriously compromised neonates.
Materials and methods
Animal preparation
The experiments were approved by the committee for animal experimentation of the
University of Maastricht. Six newborn piglets of either sex, aged 7 days and
weighing 1.9 to 3.4 kg were used in this study. Endotracheal intubation via
tracheostomy with an endotracheal tube 4.0 (ID mm) was performed after halothane
2% induction with a mask. The piglets were mechanically ventilated using a Bourns
BP 200 ventilator with a FiO2 of 0.21, ventilatory rate of 40 breath/min, PEEP of 5
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cm H2O and peak inspiratory pressure adjusted as necessary to provide a PaO2 of
10-15 kPa, PaCO2 of 5-6 kPa and a pH between 7.35 and 7.45. Anaesthesia was
further continued with halothane 1 to 1.5 %. ECG electrodes were placed to monitor
ECG and heart rate. A 6 mm precalibrated ultrasonic transit time flow transducer
(Transonic Systems Inc., Ithaca NY 14850, USA) was placed around the right
common carotid artery, for continuous measurement of Qcar.
A 4 French fibre optic catheter (Oximetric System, Abbott Laboratories, North
Chicago, IL, USA) was placed in the right femoral artery and the tip was advanced
into the abdominal aorta for registration of arterial oxygen saturation (SaO2) and
systemic blood pressure. A 5 French catheter was placed in the femoral vein for the
administration of dextrose 10% in water (6ml/hr) to maintain blood glucose
concentrations of > 4 mmol/l. Another 5 French catheter was placed in the left
femoral artery to take blood samples and for exsanguination. Rectal temperature
was measured continuously and maintained between 38.0 and 39.0 º C using a
heating mattress and heating lamps. Silver-plated isolated needle electrodes were
placed subcutaneously (two biparietal: P 3 and P 4; one frontal: F 0, according to
the 10 - 20 system of electrode placement, impedance: < 2 K Ohm) and were
connected to the CFAM. The NIRS sensor was placed in the midline (sagittal
suture) fronto-parietally. The scalp was previously shaved and cleaned with alcohol
to increase absorbency.
Arterial blood samples (0.2 ml) were obtained every 15 minutes. Blood gases and
pH (AVL, radiometer, Copenhagen, Denmark) were corrected for body temperature.
SaO2 was measured continuously with the fibre optic catheter, calibrated in vivo by
using a hemoximeter (OSM2 hemoximeter, radiometer, Copenhagen, Denmark).
SaO2, Qcar, MAP and heart rate values were digitized and displayed every second
using a haemodynamic acquisition system (HDAS) developed at the University of
Maastricht.
Experiments
The experimental protocol is shown in fig. 1. Progressive hypovolemic hypotension
was induced after a one-hour stabilization. Blood, 20 ml/kg body weight was first
withdrawn during a 15-minute period and continued in aliquots of 10 ml/kg over 15
minutes. The withdrawn blood volume required to obtain a MAP below 30 mm Hg
and severe bradycardia was 40 ml/kg (n=2), 50 ml/kg (n=2) and 60 ml/kg (n=2).
This exsanguination phase is called a crash period.
Every exsanguination period was followed by a steady state of 15 min. Blood gases
and pH were corrected if needed during the steady states using sodium
bicarbonate, tromethamine or changing ventilatory settings. Animals were under
normoxemic conditions during the whole experiment. The crash period was
followed by a steady state. Thereafter, the total blood volume previously withdrawn
was reinfused over 10 to 15 - minute period. A recovery phase of 15 minutes
followed the reinfusion of blood. At the end of the experiments all piglets were
sacrificed with an overdose of pentobarbital.
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Data sampling and analysis
The CFAM - signal is an amplified, asymmetrical filtered, amplitude integrated
three-channel EEG (P 3 - F 0, P 4 - F 0 and P 3 - P 4). EEG amplitude and
frequency content were registered by CFAM using the software program Poly
(Inspektor Research Systems BV., Amsterdam, The Netherlands). The CFAM
system used in this study has been developed by the department of Clinical
Neurophysiology, University of Maastricht (Reulen et al., 1999). CFAM depicted
three-channel unprocessed EEG, EEG amplitude and EEG frequency analysis.
Epochs of two seconds were analysed by the computer yielding EEG amplitude
(bandwidth, minimum and maximum mean) and frequency percentages of delta [1-
3.5 Hz], theta [3.5-7.5 Hz], alpha [7.5-13 Hz] and beta [13-27Hz]). Oxy-Hb and
deoxy-Hb concentration and Cytaa3 were continuously registrated by a NIRS-
system (Critikon, Cerebral RedOx Monitor 2020, Johnson & Johnson Medical). THb
was calculated from the sum of oxy-Hb and deoxy-Hb and was used as an index of
CBV. Changes in tHb are expressed as absolute percentage of baseline values,
which were considered as 100%. Cytaa3 results are changes from the baseline
value and are expressed in mol/L. The optodes of this NIRS reflectance system
are placed in a one-piece probe and the transmitted light is detected by two
detector channels at prefixed emitter-detector spacings of 10 mm and 35 mm. The
proximal detector collects light that has been predominantly transilluminated by
extracerebral tissue. To the contrary, the distal detector is reached by light that has
traveled deeper into the brain tissue. The NIRS-Critikon, Cerebral RedOx Monitor
2020 calculates Cytaa3 changes using the ratio of light detected in the two
detectors. We assumed an optical pathlength of 4.4 times the interoptode distance
(Delpy et al., 1988).
Statistical Analysis
Data acquired according to the experimental scheme showed in fig. 1 had to be
trimmed down for each piglet individually. Steady states 3, 5, 7 and 9 were left out
for the analysis and experimental phases were redefined into new periods. For
each piglet the crash phase was divided into a period in which MAP > 30 mmHg
and one in which MAP < 30 mmHg (Bunt et al., 1996) (fig. 2, periods 0 > 30 mmHg
and 0 < 30 mmHg). Using the crash moment between these new periods as a
reference point only the last and foregoing last exsanguination phases preceding
period 0 < 30 mmHg were included in the analysis (fig.2, periods -2 and -1). The
reason for this was that two piglets reached their crash period within the third
exsanguination phase, two piglets within the fourth one and two piglets within the
fifth exsanguination phase. The baseline measurements, the postcrash steady
state, the blood reinfusion phase and the recovery phase were each maintained
and redefined as new periods -3, 1, 2 and 3 respectively (fig. 2). The last ten
minutes of each period were analysed. Univariate trend analysis and bivariate,
correlational trend analysis have been done within a repeated measurements
analysis of variance ANOVA. For the univariate trend analysis reversed Helmert
contrasts have been calculated for periods -3 to 0 < 30 mmHg, in which each mean
- except that of the baseline - is contrasted with the mean of the preceding means.
Three separate simple contrasts have been calculated between period means 1, 2
and 3 versus the baseline mean. The two-paired samples comparison of variance
test was applied to test differences between the variances of the δwave % baseline
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and the 3 post crash phases. Next, a mixed model repeated measurements ANOVA
was done to assess bivariate, correlational trend analysis using CFAM and NIRS
parameters as dependents and the MAP as an independent variable. The same
contrasts were used as in the univariate analysis. Changes of pH, blood gases,
glycemia and blood haemoglobin between baseline and the analysed experimental
phases were compared by the Wilcoxon matched-pairs signed-rank test. Tests
were considered to be statistically significant at p < 0.05. Data are expressed as
mean ± SD. All calculations were made using SPSS programs, version 6.1 and 7.0
(SPSS Inc., Chicago, Illinois, USA).
Results
Table 1 summarizes the mean values for CFAM, NIRS and haemodynamic
parameters during the experiment. Table 2 shows the arterial blood gases,
glycemia and haemoglobin values measured during the experimental setting.
During progressive hypotension and before crash period:
Core temperature varied between 38.1 to 39.0ºC, blood glucose 3.1 to 6.4 mmol/L,
PaO2 11.5 to 17.6 kPa, PaCO2 3.9 to 5.9 kPa, pH 7.32 to 7.42 and blood
haemoglobin 2.2 to 6.6 g/100ml.
A positive significant correlation was found between Qcar, tHb and MAP. No
difference in the EEG amplitude was observed compared to baseline registration.
Unlike EEG amplitude, δ wave percentage began to increase at MAP below 47.9
mmHg (67 % of baseline). The negative correlation was significant (p=0.0069).
Cytaa3 did not change significantly.
Within and after crash period:
Core temperature was 38.0 to 39.00ºC, blood glucose of 2.9 to 17 mmol/L, PaO2 of
10.1 to 21.4 kPa, PaCO2 of 2.71 to 3.82 kPa, pH between 7.07 and 7.42 and
haemoglobin of 1.9 to 4.8 g/100ml.
The maximal EEG amplitude (p=0.002) decreased significantly when MAP and Qcar
dropped below 30 mm Hg (41% of baseline) and 20 ml/min (33% of baseline)
respectively. δ wave percentage increased significantly within the crash period
(p=0.0028). Thereafter, δ activity decreased significantly (p=0.016). There was a
trend toward a decrease in Cytaa3, but the difference was not statistically significant
(p=0.052).
During blood reinfusion and haemodynamic recovery:
Core temperature varied between 38.0 to 39.0ºC, blood glucose 2.4 to 7.1 mmol/L,
PaO2 of 8.33 to 20.75 kPa, PaCO2 of 3.55 to 7.67 kPa, pH between 6.78 and 7.50
and haemoglobin of 1.6 to 5.9 g/100ml.
All variables did recover to baseline values, except for EEG amplitude. EEG
amplitude was completely suppressed in one piglet despite fully haemodynamic
recovery. The mean δ wave % recuperated baseline values. To the contrary,
baseline and recovery variances were significantly different (p=0.024).
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Fig. 1 Experimental scheme of progressive hypovolemic
hypotension in newborn piglets (n=6).
▼ ✗
|___|___|___|___|___|___|___|___|___|___|___|___|___|
1 2 3 4 5 6 7 8 9 10 11 12 13
NIRS and CFAM
1 = baseline
2 = exsanguination of 20 ml/kg/15 min
3, 5, 7, 9 = steady states of 15 min
4, 6, 8 = exsanguination of 10 ml/kg/15 min
10 ▼ = last exsanguination of 10 ml/kg/15 min
or crash period
11 = post-crash steady state
12 = whole blood volume reinfusion
13 = recovery phase
✗ = euthanasia
Fig. 2 Experimental phases of progressive hypovolemic
hypotension which were statistically analysed for this study.
▼
|_____|_____|_____|_____|_____|_____|_____|_____|
-3 -2 -1 0 > 0 < 1 2 3
NIRS and CFAM
-3 = baseline
-2,-1 = first and second exsanguinations
0 > = last exsanguination with MAP>30mmHg
0 < = last exsanguination with MAP<30mmHg
1 = post-crash steady state
2 = whole blood volume reinfusion
3 = recovery phase
▼ = crash or severe hypotension and bradycardia
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Table 1 CFAM, NIRS and systemic haemodynamic parameters during progressive
hypotension in newborn piglets.
Haemodynamic parameters CFAM parameters NIRS parameters
phase MAP
(mmHg)
Qcar
(ml/min)
ECBA
(volts)
δ wave
(%)
tHb
(% from-3)
Cytaa3
( ∆mol/L)
-3 71.7±16.7 43.6±17.5 21±8 38.8±4.9 1.0±0.19 0.0±.4.2
-2 55.5±11.7* 29.2±6.99* 19.1±5.8 41.8±2.7 0.88±0.19* 0.18±3.9
-1 47.9±10.5* 23.4±4.89* 18.4±5.4 42.6±5.6 0.87±0.18* 0.24±3.5
0
(MAP>30mmHg)
33.5±5.1* 17.3±3.8* 18.2±4.9 45.3±7.8 0.84±0.17* 0.20±3.2
0
(MAP<30mmHg)
18.2±7.8** 9.7±3.7* 9.9±6* 50.5±7.8* 0.82±0.17* -0.58±2.9
1 13.6±4.9** 3.7±2.6* 1.3±1.7** 31.4±8.2* 0.76±0.15** -1.92±2.8
2 52.9±28.1 25.7±18.8 5.2±5.5** 38.6±9.4 0.89±0.21 -0.69±1.8
3 62.7±11.6 54.1±15.3 5.9±5.8* 39.4±10.4I 0.96±0.26 -0.72±3.2
Qcar=carotid blood flow, ECBA =maximal mean electrocortical brain activity, tHb=total Hb, -3=baseline, -2,-1=first and second exsanguinations,
0 MAP > 30mmHg =last exsanguination with MAP > 30mmHg, 0 MAP < 30mmHg=last exsanguination with MAP < 30mmHg, 1=post-crash steady state,
2=whole blood volume reinfusion, 3=recovery phase, * p < 0.05, ** p<0.005 according to univariate ANOVA repeated measurements design, Helmert
contrast among -3 to 0 MAP < 30mmHg. I p 0.024 according to two paired samples comparison of variance among -3 to 0 MAP < 30mmHg. Mean±SD.
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Table 2 Changes of pH, blood gases, glycemia and blood haemoglobin
during progressive hypotension and blood reinfusion in newborn
piglets.
phase pH PaO2
(kPa)
PaCO2
(kPa)
glycemia
(mmol/L)
haemoglobin
(g/100ml)
baseline 7.34±0.04 13.13±1.7 5.06±0.51 4.82±1.22 5.35±1.11
hypotension
(MAP>30mmHg)
7.36±0.03 14.69±1.8 4.94±0.54 4.54±1.83 4.62±1.25 *
haemodynamic crash
(MAP<30mmHg)
7.29±0.16 16.75±5.9 3.17±0.45
*
9.93±7.05 3.58±1.38 *
reinfusion-recovery 7.16±0.23 13.72±3.5 5.15±1.52 3.35±2.60 4.31±1.70
* p < 0.05 according to Wilcoxon matched paired signed ranks test. Mean ± SD.
Discussion
The purpose of this work was to study the effect of isolated progressive
haemorrhagic hypotension on cerebral electrocortical activity, haemodynamics and
oxygenation of newborn piglets measured by CFAM and NIRS respectively. Our
results showed that a mean arterial pressure below 30 mmHg affected cerebral
perfusion and electrocortical activity as reflected in CFAM, when the oxygen supply
was still sufficient to avoid neuronal hypoxia.
We chose the newborn piglet for our experiments because it is a well-documented
model for the study of asphyctic insults (Raju et al., 1992; Goplerud et al., 1992;
Yonetani et al., 1994; Tsuji et al., 1998). However, no information is available
regarding experiments focussing on EEG spectra and amplitude analysis in
combination with NIRS.
The brain tissue can be exposed before as well as after birth to many situations,
which could compromise its function. The single most important factor which could
induce loss of cerebral vascular autoregulation of the brain is systemic hypotension
(Bunt et al., 1996; Hellström-Westas et al., 1992). Therefore, the study of the
consequences of systemic hypotension on neuronal function could provide data of
importance for the management of neonates at risk. Severe and prolonged hypoxia,
hypotension or both lead to asphyxia. During asphyxia, compensatory mechanisms
redistribute peripheral blood flow toward vital organs reducing peripheral oxygen
consumption. In addition, cerebral vasodilatation assures appropriate cerebral
oxygen delivery. However, when associated with severe systemic hypotension,
cerebral perfusion is affected (Volpe, 1995; Iacoboni et al., 1999). Because of loss
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of cerebral vascular autoregulation, cerebral blood flow (CBF) becomes pressure
passive. Furthermore, energy failure leads to depletion of intracellular high-energy
phosphate compounds, cytotoxic edema, primary and delayed secondary neuronal
damage together with mitochondrial injury after reperfusion (Ginsberg, 1995;
Gluckman and Williams, 1992). In piglets, the reduction in CBF is most pronounced
in the cerebrum, less in the cerebellum, and least in the brainstem (Laptook et al.,
1982). The consequences on later brain development depend on the severity of this
regional damage.
In our model, we assured normocarbia, normoxia, normoglycemia and oxygen
content. Thus, the only factor, which affected cerebral perfusion, was systemic
hypotension. The level of glycemia increased during the haemodynamic crash
period. This finding, although not significant, is indicative of a sympathoadrenal
response to haemorrhagic stress. Finally, it is interesting to see that it was required
up to 59% change of MAP and 67% of Qcar to affect neuronal function. Qcar
represented cerebral blood flow. Qcar signal from the common carotid artery
ultrasonic flow probe we used has been recently validated by Meadow et al.. Qcar
corresponded to cerebral blood flow determined by radioactive microspheres in a
hypercarbic and hypoxic newborn piglet model (Meadow et al., 1999).
Conventional multichannel EEG and CFAM.
CFAM is a QEEG registration in which the EEG signal is filtered and selectively
amplified. CFAM is easy to handle allowing continuous long-term bedside
registration and on-line interpretation (Maynard and Jenkinson, 1984). Several
studies showed that electrocortical brain activity (ECBA) depicted by CFAM
correlates with that of a conventional EEG, except for the recognition of very short
seizure patterns (Greisen, 1994; Hellström-Westas, 1992; Peck et al., 1981;
Thiringer et al., 1986).
CFAM amplitude analysis
Since its first introduction by Maynard and Prior in 1969, an extensive body of
information has been written concerning its use during adult cardiopulmonary
surgery, anaesthesia and for determining brain death (Prior et al., 1971; Peck et al.,
1981; Altafullah et al., 1991; Dubois et al.,1978; Patel, 1981). Normal patterns in
premature and full-term infants have been described by several authors (Hellström-
Westas et al., 1991; Verma et al., 1984, Thornberg and Thiringer, 1990; Viniker et
al., 1984). Changes in ECBA amplitude analysis registered by CFAM have been
reported in several pathological conditions: hypoxic-ischaemic encephalopathy
(Archbald et al., 1984, Bjerre et al., 1983; Wertheim et al., 1994), seizures
(Hellström-Westas et al., 1985), monitoring anticonvulsant therapy (Hellström-
Westas et al., 1995b), after use of surfactant (Hellström-Westas et al., 1992a) and
hypoglycaemia. In addition some authors proposed the use of CFAM amplitude
patterns as a prognostic tool after hypoxic-ischaemic encephalopathy periods (Eken
et al., 1995; Hellström-Westas et al., 1995a,Thornberg and Ekström-Jodal, 1994).
Furthermore, the effects of hypoxia, ischaemia and anaesthetics on CFAM
amplitude analysis have been studied using different animal models (Bunt et al.,
1996; Aberg et al., 1989; Prior et al., 1978; Toner et al., 1995, Yuan et al., 1995). In
our experiments, no burst-suppression activity was seen which means that
halothane anaesthesia was appropriate. Hypovolemic hypotension was important
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and severe enough to induce significant systemic and cerebral haemodynamic
changes. EEG symmetry during the experiments showed that ischaemia occurred in
a global fashion. EEG amplitude decreased significantly compared to baseline
values when MAP decreased below 30 mmHg. The impact on EEG amplitude
remained even after blood reinfusion and in spite of systemic and cerebral
haemodynamic recovery. This depressed EEG amplitude reflected the severity of
the insult.
CFAM frequency analysis
Maynard reported in 1979 the first experience with EEG frequency analysis by
CFAM. Since then, contrary to amplitude analysis, spectral analysis in physiological
or pathological conditions has been not often reported. It has been reported in adults
during surgery and anaesthesia (Sebel et al., 1983; Yate et al., 1986), during
hemofiltration in patients with acute hepatic and renal failure (Davenport and
Bramley, 1993), predicting neurological outcome after cardiopulmonary bypass
surgery and in pediatric intensive care (Tasker et al., 1990). There are no data
concerning clinical or experimental studies neither in human newborns nor in
newborn animals.
Different EEG features have to be considered to evaluate spectral power. Such as
dominance, reactivity, variability and topography of the EEG frequencies (Prior,
1993). In this study, δ frequency was analysed. The dominant frequencyδ band was
chosen for three reasons. First, the neonatal basic frequency spectra of EEG ranged
between 3 to 4 Hz, showing a dominant δ band. EEG spectral patterns similar to
those found in adults develop later at 5 years of life. Secondly, inhalational
anaesthetics slow the EEG spectral power (Wauquier, 1993). Additionally, halothane
increases the dominant frequency prior to anaesthesia. These two factors explain
the dominance of δ activity throughout the experiment. However, the experiments
were started after one hour of stabilization under a constant dose of anaesthetic and
further no changes in EEG amplitude or spectral power. Finally, increase in δ wave
activity is associated with low levels of consciousness, severe hypocarbia, seizure
disorders, cerebral trauma, post-hypoxic encephalopathy and brain ischaemia
(Fisch, 1991).
In this work, although there were no significant differences, the increase in δ wave
percentage activity was consistent when MAP was below 47mmHg (63 % of
baseline). The augmentation of δ wave activity within the crash period (p=0.028)
represented impairment of neuronal function. Mean δwave % recuperated baseline
values during blood reinfusion and the recovery phase. However, the difference
between baseline and recovery variances was statistically significant (p=0.024). This
phenomenon demonstrated the important heterogeneity of brain function during
recovery.
Near infrared spectroscopy (NIRS)
NIRS provides a noninvasive tissue oxygenation and blood volume monitoring. The
application of cerebral NIRS to animal studies was first reported by Jobsis in 1977.
Since then, several studies have validated and documented the value of NIRS in
specific clinical and experimental situations (Jeni et al., 1996; Takei et al., 1993;
Nomura et al., 1996). The NIRS-Critikon software calculates the changes in optical
absorption of near infrared light and converts these into changes of HbO2, Hb, tHb
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and the oxidation-reduction state of Cytaa3.
It was observed that MAP and Cytaa3 were independent from each other. Cytaa3
showed a consistent but not a significant increase during hypotension, as long MAP
remained > 30 mmHg. In contrast, the haemodynamic crash and reperfusion were
associated with an insignificant reduction of Cytaa3. Similar but significant Cytaa3
changes have been previously reported in other animal models and have been
positive correlated with oxygen delivery. Tsuji et al. (1995) showed a significantly
decreased Cytaa3 when MAP dropped below 17 mmHg in combination with severe
hypoxemia in the neonatal piglet. Shadid et al. reported a significant increase of
Cytaa3 during hypercapnic hypoxia in newborn lambs, followed by an important
decrease when haemorragic hypotension was added. In our experiments, in spite of
severe systemic and cerebral haemodynamic changes at MAP < 30 mmHg, the
tissue concentration of Cytaa3 decreased but showed no statistical significance. This
suggests sufficient mitochondrial respiration during hypotension and reperfusion,
reflecting the efficiency of adaptive mechanisms to maintain neuronal oxygen levels.
The fact that Cytaa3 changes were not significant at any degree of hypotension
might be due to the fact that normoxia was achieved throughout all the experimental
phases. We did not performed jugular venous bulb oximetry, but we could assume
that oxygen extraction was sufficient.
Critical values of MAP and Qcar before the haemodynamic “crash” led to moderate
but significant changes of tHb or CBV without an impact on ECBA. There is,
however, an important fact to be pointed out regarding the interpretation of the tHb
data. As shown in table 2, blood haemoglobin concentration decreased significantly
during exsanguination. This haemorrhagic haemodilution invalidated the reliability of
tHb, since changes in concentration of tHb will reflect changes in CBV only if the
blood Hb concentration remains stable (Tsuji et al., 1995; Bucher et al., 1994).
Therefore, we speculate that changes of tHb or CBV were actually less important.
This has been recently demonstrated in a piglet model of non-haemorrhagic
hypotension (Tsuji et al., 1998).
The ranges for PaCO2 during hypotension and reperfusion were 2.71 to 7.67 kPa.
Only the PaCO2 variations during the crash period were significantly lower compared
to baseline (table 2). Moderate hypocarbia leads to a reduction in CBF without
changes in oxidative mechanisms. Only if PaCO2 falls to less than 2.66 Kpa, the
reduction is associated with mild reduction in cerebral oxidative mechanisms
(Perlman, 1998). In our model, the pattern of CFAM changes during reperfusion and
the unchanged redox state of Cytaa3 indicated the absence of permanent neuronal
damage. Therefore, it can be assumed that hypocarbic vasoconstriction during the
crash period was not enough to affect cerebral oxidative mechanisms (Wyatt et al.,
1993).
In summary, our data show that neuronal activity is only affected when changes in
cerebral perfusion are severe. Furthermore, electrocortical activity is depressed at a
higher MAP and level of cerebral haemodynamics and oxygenation than those
changes associated with neuronal hypoxia. Neuronal oxygenation might remain
sufficient if normoxemia is assured during severe hypotension. These data support
our primary statement that continuous monitoring of cerebral electrical activity is
relevant during routine intensive neonatal care.
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CHAPTER 7.
NEONATAL ELECTROCORTICAL BRAIN ACTIVITY AND
CEREBRAL TISSUE OXYGENATION DURING NON-
ACIDOTIC, NORMOCARBIC AND NORMOTENSIVE
GRADED HYPOXEMIA
AWD Gavilanes, JSH Vles, K von Siebenthal, R van Sprundel, JPH Reulen, and
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Abstract
Objective: Neonates are commonly exposed to isolated hypoxemic episodes. In
order to identify the risk of this, we correlate cerebral oxygen delivery and
electrocortical brain activity during isolated graded and repetitive hypoxemia in 1-
week-old piglets.
Methods: Six halothane-anaesthetized piglets were subjected to two episodes of
graded hypoxemia of 45 min-duration. The fractional concentration of inspired
oxygen (FiO2) was stepwise decreased at 15-min intervals from 0.21 to 0.15, 0.10
and 0.05. A second identical hypoxemic event was induced after one-hour of
normoxemia (FiO2 0.21). Mean arterial pressure (MAP) and pH were maintained at
baseline values during the whole experiment. We measured near infrared
spectroscopy parameters [cerebral oxidized cytochrome aa3 (Cytaa3), total
haemoglobin (tHb: oxy- + deoxyhaemoglobin)] corresponding to cerebral blood
volume (CBV), carotid blood flow (Qcar), intra-arterial oxygen saturation (SaO2), and
mean maximal EEG amplitude and relative spectral power.
Results: Delta (δ) power increased significantly and the EEG amplitude dropped
below 10 and 5 µvolts at the end of the first and the second hypoxemic period [PaO2
2.68±1,08 (p<0.05) and 2.87±0.58 kPa, respectively]. Both EEG variables
normalized during recovery (FiO2 0.21). Qcar, CBV and Cytaa3 were not changed.
Conclusion: Acute isolated hypoxemia has to be sustained to induce neuronal
hypofunction in normotensive animals. Hypoxic hypoxemia led to acute changes in
neuronal activity, whereas cellular oxygenation remained unaffected.
Key words
Maastricht Cerebral Monitor - Electroencephalogram - Hypoxemia - Hypoxia - Near
Infrared Spectroscopy - Newborn - Piglet
Abbreviations
CFM : cerebral function monitor
CFAM : cerebral function analising monitor
CBF : cerebral blood flow
CBV : cerebral blood volume
Cytaa3 : oxidized cytochrome aa3
deoxy-Hb : deoxyhaemoglobin
ECBA : electrocortical brain activity
EEG : electroencephalogram
MCM : Maastricht cerebral monitor
MAP : mean arterial blood pressure
NIRS : near infrared spectroscopy
NO : nitric oxide
oxy-Hb : oxyhaemoglobin
Qcar : carotid blood flow
QEEG : quantitative electroencephalogram
SaO2 : intra-arterial oxygen saturation
tHb : total haemoglobin (oxy- + deoxyhaemoglobin)
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1. Introduction
Global ischemic and hypoxemic insults are common in neonatal intensive care
and may cause permanent brain damage. Therefore, the on-line monitoring of
cerebral oxygenation and neuronal function variables during neonatal intensive
care could yield useful information complementary to systemic haemodynamic and
respiratory variables.
During moderate hypoxemia, the sympathetic-adrenergic system is activated,
redistributing blood flow in favor of brain, heart and adrenals. Concurrently, early
electrical hypofunction is manifested (Volpe, 2001). The compensatory
increased cerebral perfusion, and an accelerated compensatory anaerobic
glycolysis, initially protects the brain tissue from hypoxemic metabolism. Severe
hypoxemia, however, causes cardiovascular depression with significant systemic
hypotension, impairing cerebral perfusion (Tsuji et al., 1995; Volpe, 2001).
Furthermore, loss of vascular autoregulation and a mitochondrial oxygen tension
below 0.1 mmHg provoke desaturation of the cytosolic energy system and
compensatory glycolysis becomes inefficient. Therefore, EEG alterations seem
to precede loss of autoregulation, metabolic depletion and cell damage. A
potential explanation for these early electrical changes is the role of adenosine.
Adenosine is increased in the interstitial space, releasing intracellular potassium
and inhibiting postsynaptic potentials early during moderate hypoxemia. In
addition, adenosine may further depress calcium conductance. The actions of
adenosine on potassium and calcium metabolism make the cell less electrically
excitable and spare cell energy avoiding metabolic failure and irreversible cell
damage (Rothman, 1998).
The Maastricht Cerebral Monitor (MCM) and near infrared spectroscopy (NIRS)
are two on-line tools to monitor cerebral electrocortical function and oxygenation
changes, respectively. NIRS refers to an optical technique that assesses circulation
and oxygenation. This method allows measurement of changes in cerebral
oxyhaemoglobin (oxy-Hb), deoxyhaemoglobin (deoxy-Hb), total Hb (tHb) and in the
level of Cytaa3. The MCM is a new computerized MCM system developed by the
authors. It is an asymmetrical filtered, amplitude-integrated quantitative EEG
(QEEG), which additionally analyses the EEG frequency content (Reulen et al.,
1999). We first reported QEEG frequency spectral analysis in a piglet model of
isolated hypovolemic hypotension (Gavilanes et al., 2001), using MCM and a NIRS
apparatus. We showed that electrocortical function is affected only by profound
systemic hypotension. This occurred at a higher level of cerebral oxygen delivery
than the level associated with neuronal hypoxemia. In the present study the effect
of repeated non-acidotic, normotensive hypoxic hypoxemia on cortical neuronal
function and cerebral oxygen delivery is evaluated. MCM and NIRS are used as
monitors to obtain more insights into the adaptive mechanisms of the neonatal brain
subjected to impaired oxygenation.
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2. Materials and methods
2.1. Animal and surgical procedures
A total of six piglets of one week of age were used in accordance with the committee
for animal experimentation of the University of Maastricht. Animals were initially
anaesthetized using halothane 2% induction with a face mask and endotracheal
intubated via tracheostomy with an endotracheal tube 4.0 (ID mm). The piglets were
positive pressure ventilated (Bourns BP 200) with a fractional concentration of inspired
oxygen (FiO2) of 0.21, a ventilation rate of 40 breaths/min, PEEP of 5 cm H2O and PIP
adjusted as necessary to provide acceptable chest wall movement and arterial blood
gases (PaO2 of 10-15 kPa, PaCO2 of 4.5-6 kPa and pH of 7.35-7.45). Anaesthesia was
then maintained with halothane 1.0 to 1.5 %. Continuous three-lead ECG was
recorded throughout the experiment. A 6 mm precalibrated ultrasonic blood volume
flow probe (Transonic Systems Inc., Ithaca NY 14850, USA) was placed around the
right common carotid artery to measure Qcar. The right femoral artery was cannulated
with a 4 French fibre optic catheter (Oximetric System, Abbott Laboratories, North
Chicago, IL, USA) to record systemic blood pressure and intra-arterial oxygen
saturation (SaO2). A 5 French catheter was placed in the left femoral artery to take
blood samples. Another 5 French catheter was inserted into the femoral vein for the
administration of D10W, 2.5 ml/kg per hour. Rectal temperature was monitored
throughout the experiment and maintained between 38.0 and 39.0° C’s by the use of a
heating mattress and heating lamps. Brain activity using MCM was monitored between
three silver-plated isolated needle electrodes that were placed into the scalp (one mid-
frontal and two parietal electrodes, impedance: < 2 K Ohm). The NIRS sensor was
placed in the midline fronto-parietally and fixed with bandages. The scalp was
previously shaved and cleaned with alcohol to increase light penetration. Arterial blood
samples (0.2 ml) were obtained at 15 min-interval to determine serum glucose
concentration, haemoglobin, blood gases and pH (ABL, Radiometer, Copenhagen,
Denmark; measurements corrected for body temperature). SaO2 was measured
continuously with the fibre optic catheter, and calibrated in vivo by using a hemoxime-
ter (OSM2 hemoximeter, radiometer, Copenhagen, Denmark).
2.2. Experimental protocol (fig.1)
After one-hour initial period of postsurgical baseline measurements, the animals
were challenged with two episodes of hypoxemia of 45 min-duration (episodes a and
b). Each episode consisted of three phases of hypoxemia. Each phase lasted 15 min.
Hypoxemia was induced by changing the proportion of oxygen/nitrogen in the
inspiratory gas. FiO2 was reduced from 0.21 to 0.15, to 0.10 and finally to 0.05. The
second identical hypoxemic episode was induced after one-hour recovery/baseline
under normoxic conditions (FiO2 0.21). PaCO2 and pH were corrected if needed using
sodium bicarbonate, tromethamine or changing ventilatory settings. Polygeline
(Haemaccel, HMR) 10 ml/kg IV was used as volume expander when necessary to
maintain MAP above 40 mmHg. At the end of the experiments all piglets were killed
using a high-dose pentobarbital.
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Fig. 1
Experimental scheme of two episodes of graded
hypoxic hypoxemia in newborn piglets (n=6).
†
|____|____|____|____|____|____|____|____|____|____|
1 2 3 4 5 6 7 8 9 10
NIRS and MCM
1: baseline a / 1 hour
2: FiO2 0.15 / 15 min
3: FiO2 0.10 / 15 min
4: FiO2 0.05 / 15 min
5: recovery a FiO2 0.21 / 15 min
6: baseline b / 45 min
7: FiO2 0.15 / 15 min
8: FiO2 0.10 / 15 min
9: FiO2 0.05 / 15 min
10: recovery b FiO2 0.21 / 15 min
†: euthanasia
2.3. Analysis of data
SaO2, Qcar, MAP and heart rate were monitored every second using a home-made
haemodynamic acquisition system (HDAS).
The computerized MCM system used in the experiments has been developed by
the authors, and it has been described before (Reulen et al., 1999). MCM depicted
three-channel unprocessed EEG, EEG amplitude and EEG frequency analysis.
Epochs of two seconds were analyzed by the computer yielding EEG amplitude
(bandwidth, minimum, maximum and mean) and relative delta [1-3.5 Hz], theta [3.5-
7.5 Hz], alpha [7.5-13 Hz] and beta [13-27Hz] power. Only the biparietal MCM
recording was further analyzed and defined as ECBA.
The redox state of the Hb and cerebral Cytaa3 was calculated by a NIRS-
instrument (Critikon, Cerebral RedOx Monitor 2020, Johnson & Johnson Medical
Ltd., Norderstedt, Germany) and saved every second. THb was calculated from the
sum of oxy-Hb and deoxy-Hb and was used as an index of CBV. THb and Cytaa3
data are absolute changes from the baseline value and are expressed in µmol/L.
The optodes of this NIRS reflectance system are placed in a one-piece probe and
two detector channels at emitter-detector spacing of 10 mm and 35 mm detect the
transmitted light. The proximal and the distal detectors perceive light that has been
transilluminated by extracerebral tissue and brain tissue, respectively. Cerebral
Cytaa3 is calculated by correction for the proximal sample. The optical pathlength of
4.4 times the interoptode distance (Delpy et al., 1988).
2.4. Statistics
The last five minutes of each experimental phase were analyzed. The second
hypoxemic period was analyzed in four out of six animals (for details see results).
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Statistical analysis within each hypoxemic period and between the two hypoxemic
periods was done by the non-parametric Wilcoxon matched-pairs signed-rank test.
All calculations were made using SPSS programs, version 8.0 (SPSS Inc., Chicago,
Illinois, USA). Data are expressed as mean ± SD. The criterion for significance was
p < 0.05 level and highly significant at the p < 0.005 level.
3. Results
Six male piglets, aged 7 days and weighing 2.3 to 3.9 kg were used in this study.
Values for MCM, NIRS and haemodynamic parameters, and for arterial blood gases
are shown in table 1 and 2. Core temperature (38.0 to 39.0°C), glycemia and
haemoglobin remained within baseline ranges (data not shown). No significant
differences in MCM, NIRS and haemodynamic parameters were found between the
baseline phases of the two hypoxemic episodes.
3.1. The first episode of graded hypoxemia, episode a (n=6):
Compared to baseline, EEG amplitude and δ wave percentage remained
unchanged during the first 30 minutes of hypoxemia (FiO2 0.15 - 0.10). In the last 15
minutes (FiO2 0.05), SaO2 below 24.1% (25 % of baseline) and PaO2 of 2.68 ± 1,08
kPa induced significant changes in these two EEG variables (p<0.05). All animals
had unaltered pH and PaCO2 above 3.95 kPa during the whole hypoxic episode.
MAP, Qcar, tHb and Cytaa3 did not change significantly.
3.2. Recovery a: first reoxygenation and haemodynamic recovery (n=6):
One piglet needed 10 ml/kg non-blood volume expanders to return MAP to values
> 40 mmHg. Systemic oxygenation returned to baseline values within 5 minutes. The
completely recovery of EEG amplitude and EEG δ frequency percentage took place
at the end of this period.
3.3. The second episode of graded hypoxemia, episode b (n=4):
All animals survived the first hypoxemic episode, but one died after 30 min of
normoxemia. Furthermore, data of one out of five survivors could not be further
analyzed because of artefactual MCM data.
The maximal EEG amplitude decreased and the percentage δ power increased
significantly (p<0.05) when SaO2 dropped below 23.5 % (25% of baseline, p<0.05).
MAP, pH, Qcar, tHb and Cytaa3 remained unaltered.
3.4. Recovery b: the second reoxygenation and haemodynamic recovery (n=2):
MCM and NIRS data of two animals were lacking. Therefore, this phase was
not statistically analyzed. The few data suggested that the decrease of the EEG
amplitude and increase in δ power were reversible.
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Table 2. Blood gas values during graded and repetitive hypoxemia in
newborn piglets
phase pH PaO2
(kPa)
PaCO2
(kPa)
baseline a
(n=6)
7.36±0.03 10.61±0.63 5.20±0.43
FiO2 0.15 a 7.37±0.04 6.27±0.98** 4.75±0.42*
FiO2 0.10 a 7.38±0.05 2.96±0.40** 4.43±0.68
FiO2 0.05 a 7.34±0.05 2.68±1.08* 3.95±1.33
recovery a 7.33±0.06 9.77±2.83 4.09±0.19*
baseline b
(n=4)
7.41±0.06 9.91±0.90 4.91±0.83
FiO2 0.15 b 7.40±0.05 8.33±1.67 5.20±0.81
FiO2 0.10 b 7.42±0.04 4.95±1.64* 4.60±0.72*
FiO2 0.05 b 7.34±0.08 2.87±0.58 (n=1) 4.20±0.93
recovery b 7.49±0.17(n=2) 10.70 (n=1) 2.47±1.36 (n=2)
* p < 0.05 and ** p<0.005 according to non-parametric Wilcoxon matched-pairs signed-rank
test.; n=number of experiments. Data were not analyzed. Mean ± SD.
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Table 1. MCM, NIRS, MAP,Qcar and haematologic values during graded hypoxemia
HAEMODYNAMICS NIRS MCM
phase SaO2
(%)
MAP
(mmHg)
Qcar
(ml/min)
tHb
(µmol/L)
Cytaa3
(µmol/L)
ECBA
(µvolts)
δ power
(%)
baseline a
(n = 6)
96.3±1.9 83.5±17.6 48.6±24.1 0.00±15.3 0.00±.0.3 25.0±8.8 38.9±7.7
FiO2 0.15 a 78.0±7.9* 79.5±10.4 37.3±14.0 5.2±10 0.22± 0.9 27.1±10.0 38.2±6.3
FiO2 0.10 a 41.8±16.5** 70.4±20.0 40,1±16.7 12.7±12.3 0.26±1.1 15.0±11.2 46.9±6.0
FiO2 0.05 a 24.1±12.9** 53.2±16.4 51.2±13.6 13.6±11.6 0.35±0.8 9.4±5.1* 54.5± 3.6*
recovery a 94.9±3.1 58.7±17.0 45.4±23.2 8.1 ±10.4 -0.23±1.0 19.3±5.1 41.3±9.8
baseline b
(n=4)
94.7±0.6 74.5±4.3 53.9±19.6 0.0±23.4 0.00±.0.5 22.0±3.0 37.9±4.2
FiO2 0.15 b 82.2±4.2* 71.6±6.4 56.87±24.7 1.4±1.9 0.55±.0.2 23.0.±4.9 37.3±6.4
FiO2 0.10 b 43.3±17.1* 58.2±24.6 25.1±14.6 4.7±12.6 0.91±0.6 13.2±6.4 51.1±8.4
FiO2 0.05 b 23.5±6.0** 47.8±13.8 32.7±13.5 8.5±13.4 0.77±0.9 4.7±5.1* 52.7±9.1*
recovery b 65.0±39.5 30.7±28.2 23.6±20.6 -11.3±7.7 (n=2) -0.23±0.7 (n=2) 10.6±14.1(n=2) 43.2±12.9 (n=2)
SaO2: intra-arterial oxygen saturation; MAP: mean arterial blood pressure; Qcar: carotid blood flow, ECBA: maximal mean electrocortical brain activity; Delta (δ) wave frequency
percentage; tHb: total Hb; Cytaa3: oxidized cytochrome aa3. * p < 0.05 and ** p<0.005 according to non-parametric Wilcoxon matched-pairs signed-rank test. n: number of
experiments. Data were not analyzed . Mean ± SD.
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4. Discussion
We evaluated the progression of changes in cerebral electrocortical activity after
repeated hypoxemic episodes in newborn piglets. The results show that
normotensive, non-acidotic, normocarbic, graded and repetitive hypoxemia induces
electrocortical hypofunction, whilst oxygen supply remained sufficient, assuring
neuronal integrity.
In physiological conditions, cerebral blood flow (CBF) autoregulation maintains an
adequate blood supply over a certain range of cerebral perfusion pressure (Volpe,
1991). During hypoxemia, neuronal oxygen consumption is assured by an
increased oxygen delivery (DO2) through increased cerebral perfusion and
increased oxygen extraction (VO2). However, cerebral perfusion is affected when
severe systemic hypotension is superimposed (Johnston et al., 2001).
Subsequently, both DO2 and VO2 decline below a critical level. Our previous studies
tested the effect of hypoxia-ischemia (Bunt et al., 1996) and the impact of normoxic
haemorrhagic hypotension on electrocortical brain activity (ECBA) (Gavilanes et al.,
2001). This report describes the impact of a range of hypoxemic levels on ECBA.
Hypoxemia, as part of severe acute neonatal respiratory failure, is a common
feature in neonatal intensive care. Hypoxemia due to intrapulmonary shunting is
related to parenchymal pulmonary disease (e.g., respiratory-distress syndrome and
meconium aspiration syndrome) and to persistent pulmonary hypertension of the
neonate. Less frequently, extrapulmonary shunting (e.g., congenital heart diseases
and vascular diseases) implicates acute or chronic hypoxemia. Both conditions
however do not necessarily cause a global hypoxia. Strategies to improve gas
exchange are aimed at preventing hypoxia and hypoventilation but may also
contribute to lung injury and secondary oxygen-dependent chronic lung pathology.
A considerable number of NICU patients suffer from isolated (normocarbic and
normotensive) hypoxic hypoxemia. In the animal model reported here, we have tried
to mimic this acute neonatal isolated hypoxemia in order to study its mechanism of
action.
4.1. Characteristics of the model
The piglet model used was non-acidotic, normocarbic, normoglycemic and
normotensive. The only factor, which affected ECBA, was hypoxemia. SaO2 had to
decline to 25 % of its baseline value before the EEG parameters were significantly
reduced
.
Further, MAP remained above 40 mmHg during both hypoxemic insults.
Neuronal hypofunction, as confirmed by low amplitude EEG and increased δ
power, was induced by oxygen-restricted metabolism, although without reaching
critical hypoxic levels nor irreversible neuronal injury. This conclusion is supported
by a sufficient cell oxygenation (Cytaa3) and the reversibility of the EEG parameters
by normoxemia. We assume that the threshold of cellular oxygen deficits is lower in
our model than the PaO2 < 5.3 kPa proposed by Torrance and Wittnich. In contrast to
our results, their hypoxic 3-days-old piglet model showed lactic acidemia at PaO2
values below 5.3 kPa (Torrance and Wittnich, 1994).
Anaesthesia was achieved with halothane. This gas increases slow-wave EEG
power and the dominant frequency prior to anaesthesia (Wauquier, 1993). In
addition, our experiments were started after one-hour stabilization period under a
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constant dose of anaesthetic and only when no further changes in EEG amplitude or
spectral power were seen.
Finally, Qcar represents CBF. Meadow et al. (1999) demonstrated that a Qcar signal
from the common carotid artery corresponded to CBF as determined by radioactive
microspheres in a hypercarbic and hypoxic newborn piglet model.
4.2. MCM and conventional EEG
Continuous recording of traditional multi-channel EEG identifies clinical and
subclinical seizure activity and enables the assessment of background activity
(amplitude and frequency spectra) during physiological and pathological states.
Additionally, EEG background activity could be correlated to long-term neurological
outcome. It has been demonstrated that the EEG parameters depicted by the MCM
correspond with that of conventional EEG (Peck et al., 1981; Thiringer et al., 1986;
Hellström-Westas, 1992; Greisen, 1994; al Naqeeb et al., 1999). Though,
conventional EEG offers a greater reliability when diagnosing short subclinical
seizures (Selton D and Andre M., 1997).
4.3. MCM amplitude and power analysis
MCM amplitude patterns have been described in normal premature and full-term
infants (Verma et al., 1984; Viniker et al., 1984; Thornberg and Thiringer, 1990;
Hellström-Westas et al., 1991), and in several pathological conditions, including it’s
use as a predictor of neurological outcome after hypoxic-ischemic encephalopathy in
full-term infants (Toet et al., 1999). Furthermore, since its first report by Maynard in
1979, EEG frequency analysis in experimental studies of fetal or newborn animals
have been scarce (Keunen et al., 2000; Gavilanes et al., 2001). Spectral power in the
δ band was analyzed for several reasons. First, the neonatal basic frequency
spectrum ranges between 3 to 4 Hz. Additionally, inhalational anaesthetics increase
slow-wave EEG activity (Wauquier, 1993). This influence could explain the
dominance of δ activity as well as the decrease of variability of the other waves
throughout the experiment. Finally, an increase in δwave activity has been reported
during post-hypoxic encephalopathy (Fisch, 1991). In this work, δ frequency
percentage increased markedly during severe hypoxemia (p<0.05) and recovered to
baseline values during reoxygenation (FiO2 0.21).
4.4. Near infrared spectroscopy (NIRS)
The NIRS-Critikon software calculates regional changes in optical absorption of
near infrared light and converts these into changes in the redox state of haemo-
globin and Cytaa3, providing a noninvasive monitoring technique of the delivery
and utilization of oxygen to and by the brain tissue (Siebenthal and Casaer, 1992).
Data of several studies have validated and documented the value of NIRS in
specific experimental and clinical situations. Tsuji et al. (1995), and more recently
Chang et al. (1999) showed a significant decrease in Cytaa3 with a concomitant
loss of cerebral energy during combined hypoxia and ischemia in the newborn
piglet. Shadid et al. (1999) found an increase of Cytaa3 during hypercapnic
hypoxia, followed by a significant decrease during haemorrhagic hypotension.
Nomura et al. (1996) documented a decreased Cytaa3 during hypothermic
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cardiopulmonary bypass in 1 to 2 week old piglets. Hypothermic cardiopulmonary
bypass in infants less than 11 months old also showed similar patterns of Cytaa3
changes (van Bel et al., 1996). Finally, CBV and Cytaa3 were impaired in the early
postasphyctic period in neonates of > 34 weeks gestational age (van Bel et al.,
1993).
The combination of EEG amplitude, but not power analysis, and Cytaa3
monitoring has been previously reported. Marks et al. (1996) showed that ECBA
was depressed and Cytaa3 was decreased during and after 30 min of bilateral
carotid occlusion in ischemic fetal sheep. Finally, EEG changes occurred at a
higher level of oxygenation (FiO2 0.15) than those at which Cytaa3 fell (FiO2 0.10)
in an hypoxic adult rat model (Hoshi et al., 1997). These data all support the
correlation between the cellular oxygen state with the redox state of Cytaa3.
However, the latter is also influenced by several biochemical changes. Cytaa3
alterations could represent the metabolic effects of PaCO2 through intracellular pH,
energy compounds and nitric oxide (NO), rather than an increased oxygen delivery
(Edwards et al., 1991; Quaresima et al., 1998). The vascular role of NO, a diffusible
free radical synthesized under the influence of cytosolic calcium in endothelial cells
and neurons, is to coordinate perfusion by vasodilation and to modulate neuronal
activity. During hypoxic-ischemic encephalopathy, NO production is pathologically
increased and NO binds to the oxygen binding site of Cytaa3, inducing a reversible
inhibition of Cytaa3. To the contrary, more severe asphyctic insults result in higher
NO levels and with an irreversible inhibition of Cytaa3 and cell respiration by
peroxynitrites (Brown, 1999). In this study, tHb as an index of CBV did not change
during hypoxemia as compared to baseline, neither did Cytaa3. Both NIRS
measurements had the tendency toward an augmentation during hypoxemia, yet
this effect had no statistical significance. The lack of changes in cerebral circulation
and neuronal oxygenation could be explained by the sufficient cerebral perfusion
being supplied by arterial tension and normocarbia. In contrast to the above
studies, our model induced isolated hypoxemia. NIRS showed an appropriate
cellular oxygenation pattern, which paralleled ECBA hypofunction during both of the
0.05 FiO2 hypoxemic phases.
In summary, this paper reports for the first time MCM relative spectral δ power
and NIRS changes in a newborn model of isolated hypoxemia in the piglet. Our
data showed that isolated, graded and repetitive hypoxemia induces electrocortical
hypofunction whilst maintaining cellular oxygenation. These data support our
primary statement that continuous monitoring of cerebral electrical activity is
relevant during routine intensive neonatal care.
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CHAPTER 8.
ELECTRICAL BRAIN ACTIVITY DURING
NORMOTENSIVE HYPOXEMIA IN VERY LOW BIRTH
WEIGHT INFANTS
AWD Gavilanes, JSH Vles, M.van Reisen, VHJM van Kranen-Mastenbroek, JPH
Reulen and CE Blanco.
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Abstract
The aim of the study was to determine whether acute isolated hypoxemic events
could cause simultaneous neuronal dysfunction in the preterm brain during the
immediately postnatal period. Electrical brain activity was monitored with an
amplitude-integrated quantitative electroencephalogram called the Maastricht
cerebral monitor (MCM), from 12 up to 72 hours postnatally in fourteen very low
birth weight infants (VLBWI: <1500 g birth weight). The last five min of each
hypoxemic episode (arterial oxygen saturation [SaO2 ] < 0.86) were compared with
the last five min of the previous normoxic period (SaO2 > 0.86, baseline) and with
the first five min of the normoxic recovery.
Eight VLBWI (57% of eligible; gestational age: 24 to 31 weeks; birth weight: 575-
1470 g) exhibited 66 episodes of isolated hypoxemia (SaO2 0.85 to 0.67). MCM
amplitude analysis during hypoxemia, relative spectral power, raw EEG and MCM
amplitude patterns were comparable to baseline and recovery values.
Normotensive preterm infants without encephalopathy maintained an unchanged
electrical brain activity under isolated moderate acute hypoxemia. These data
suggest that the limit of hypoxemia used in clinical medicine (SaO2 of 0.85) is
significant higher than the neuronal hypoxic threshold. At that given level, adaptive
response to hypoxemia and neuronal oxygen extraction assures an appropriate
oxygen metabolism.
Key words
Maastricht Cerebral Monitor - Electroencephalogram - Hypoxemia - Hypoxia -
Very low birth weight infants - NICU
Abbreviations
aEEG : amplitude-integrated electroencephalogram
CFM : cerebral function monitor
CBF : cerebral blood flow
EEG : electroencephalogram
MCM : Maastricht cerebral monitor
NICU : neonatal intensive care unit
SaO2 : transcutaneous arterial oxygen saturation
VLBWI : very low birth weight infants
Introduction
Severely ill preterm newborn infants, requiring respiratory and circulatory support,
are commonly exposed to acute, short and repetitive hypoxemic insults. Potentially,
these insults can cause brain injury and long-term neurodevelopmental disabilities.
Monitoring electrical brain activity could therefore help to identify those infants with
neuronal dysfunction and those with seizure activity, helping to establish a prompt
clinical intervention. However, the logistics necessary to arrange and to perform a
multichannel conventional electroencephalogram (EEG) and the complexity of its
interpretation have reduced considerably its implementation as an on-line
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monitoring tool in the neonatal care. By contrast, amplitude-integrated EEG (aEEG)
using a one-channel biparietal EEG lead cerebral function monitor (CFM) has
become a standard in some neonatal units, dealing traditionally with full-term post-
asphyctic infants rather than non-asphyctic extremely preterm infants.
Literature is scarce about electrical brain activity in very low birth weight infants
(VLBWI) depicted by EEG as well as by aEEG and it mainly involved infants older
than 28 weeks gestation (2, 16). Furthermore, the relationship between acute
hypoxic hypoxia and electrical brain activity has not been evaluated in VLBWI.
In the past years, we performed a series of fetal and neonatal animal experiments
using the Maastricht cerebral monitor (MCM), a three-channel computerized
quantitative aEEG registration (9,11,21,24). After completing its development and
testing its reliability, we implemented MCM clinically. In particular, the study of
graded hypoxemia in a normotensive, non-acidotic newborn piglet model lend the
basis for the present study (12). That study showed that only severe isolated graded
hypoxemia led to acute changes in neuronal activity, whereas cellular oxygenation
remained unaffected. In this animal model, a SaO2 under 0.20 (PaO2 2.68 ± 1.08
kPa) was necessary to obtain significant MCM amplitude and spectral changes.
Although the experimental setting mimicked the clinical situation, MCM changes
were induced in the full-term anaesthetized piglet brain. Therefore, we conducted
the present study in order to investigate whether acute hypoxemic events would
cause electrical brain changes in non-anesthetized VLBWI without encephalopathy.
We expected EEG changes in terms of electrical hypofunction or dysfunction during
hypoxemia, and their normalization during normoxemic recovery.
Patients and methods
We prospectively studied fourteen VLBWI born between 24 and 31 weeks
gestational age (GA), admitted to the neonatal intensive care unit (NICU) at the
University Hospital of Maastricht over an 18-month period. Oral parental consent
was obtained from both parents. We included in this study VLBWI with normal
parenchymal cranial ultrasound scans (US), without clinical signs of perinatal
hypoxic ischemic encephalopathy (HIE) (umbilical artery pH>7.0) or other
encephalopathies. Continuous time synchronized data included heart rate, mean
arterial blood pressure and postductal SaO2 measurements (Hewlett-Packard
Neonatal Component Monitoring System, Palo Alto, CA, USA). Our policy with
regard to normal SaO2 settings in preterm infants established a lower limit of 0.86
and an upper limit of 0.93. Therefore, hypoxemia was defined as a SaO2 of less
than or equal to 0.85 (29).
MCM registration
The MCM system has been previously described by Reulen et al.(24). It plotted
and computed the weighted EEG amplitude distribution (maximum mean, minimum
mean , and bandwidth mean) in µV, and relative spectral power (delta (δ) [1-3.5
Hz], theta (θ) [3.5-7.5 Hz], alpha (α) [7.5-13 Hz] and beta (β) [13-27Hz]) in every
two-second epoch. Electrical brain activity was recorded using the MCM from three
channels: P3-Fz, P4-Fz and P3-P4, according to the 10-20 international system.
Electrodes were applied on the scalp using electrode paste and were fixed with
collodium. The resistance was < 2 kΩ for all electrodes. Monitoring was continuous
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for periods of up to three days, starting within the first 12 hours of life after parental
consent had been obtained.
MCM analysis
Off-line quantitative amplitude and relative spectral analysis of the last five minutes
of each hypoxemic episode (SaO2 0.85 to 0.67) were compared to the last five
minutes of the previous normoxic period (baseline) and with the first five minutes of
the normoxic recovery.
MCM pattern recognition
Five minutes baseline, hypoxemia and recovery raw EEG’s and aEEG’s from
each patient were visually inspected and compared for continuity or discontinuity,
and for low or normal voltage. Features taking into account in visual inspection
were the suppression duration, burst activity and burst amplitude.
Satistics
Statistical analysis was done by the repeated measurements analysis of variance
ANOVA, significance at p < 0.05. Analysis was carried out using SPSS-10.0 (SPSS
Inc., Chicago, Illinois, USA).
Results
Fourteen VLBWI were eligible for MCM registration (GA: 24 to 31 weeks; birth
weight: 575 -1470 g). The mean duration of the registration was 40 hours (24 to 72
hours). Eight out of the fourteen patients exhibited episodes of isolated hypoxemia
(SaO2 < 0.86) for 5 to 15 minutes duration. Table 1 summarizes the clinical data of
those infants. Six patients of the study group needed artificial ventilation and
invasive blood pressure monitoring. Nasal continuous positive airway pressure was
needed in two other infants. All mechanically ventilated patients received narcotics
type fentanyl (1 to 2 µg/kg/hr). One of those patients was receiving dopamine 5
µg/kg/min and remained haemodinamic stable during the study period.
Intraventricular hemorrhage grade I following Volpe (28) was detected in three
patients. None of the infants presented ultrasonographic signs of brain
parenchymal pathology during the study period.
A total of 66 hypoxemic episodes (2 to 17 episodes per patient) were registered.
SaO2 varied between 0.67 and 0.85 during the analyzed 5 minutes period at the
end of the hypoxemic event. P3-P4 MCM amplitude did not change significantly
between the study periods: baseline (maximum mean 6.7±3.1µV, minimum mean
2.4±1.8 µV and bandwidth 4.5±2.4 µV), hypoxemia (maximum mean 7.1±5.0 µV,
minimum mean 2.9±3.4 µV and bandwidth 4.9±4.2 µV), recovery (maximum mean
6.9±3.2µV, minimum mean 2.6±2.8 µV and bandwidth 4.8±2.9 µV). Table 2
summarizes these MCM characteristics. There were no significant effects of
hypoxemia on the relative spectral power data: baseline (δ 48.2±12.6 %, θ
28.9±13.5 %, α 14.5±3.5 % and β 8.2±1.9 %), hypoxemia (δ 51.8±12.0 %, θ
27.6±11.9 %, α 12.7±2.0 % and β 7.7±2.1 %) and recovery (δ 47.0±12.5 %, θ
30.1±14.6 %, α 13.9±2.8 % and β 9.2±2.3 %).
Visual inspection of the raw EEG and MCM amplitude patterns showed
appropriate background activity for GA, which was predominantly discontinuous.
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Differences between the 3 study periods were not quantified. No seizure activity
was detected in any patient at the time of the study. As a typical illustration, figure 1
demonstrates the MCM amplitude patterns (P3-P4) during baseline, hypoxemia and
recovery in patient no. 2 (GA 25 1/7 weeks).
Table 1. Characteristics of the infants presenting hypoxemic periods (n=8)
patient
no.
GA
(wks)
BW
(percentile)
UApH clinical
diagnose
ventilation
therapy
hypoxemic
periods (n)
1 24 0/7 760 (10-50) 7.17 RDS grade 4 MV 11
2 25 1/7 730 (10) 7.11 RDS grade 2 n-CPAP 8
3 25 2/7 780 (10) 7.07 RDS grade 3 MV 2
4 25 3/7 730 (2.3–10) 7.05 RDS grade 3 MV 3
5 26 0/7 575 (2.3) 7.19 RDS grade 3 MV 17
6 27 5/7 710 (2.3-10) 7.10 RDS grade 3 MV 7
7 28 6/7 970 (10) 7.03 RDS grade 3 MV 14
8 31 0/7 1470(10-50) n.a. RDS grade 2 n-CPAP 4
GA= gestational age in weeks; BW= birth weight in grams; UapH= umbilical artery pH; n.a.= not
available; MV= mechanical ventilation; n-CPAP=nasal CPAP; RDS= respiratory distress syndrome.
Table 2. Comparison of computed MCM parameters during acute hypoxemia in
VLBWI (n=8)
MCM AMPLITUDE (µV) MCM RELATIVE SPECTRAL POWER (%)
PERIOD MAXIMUM MINIMUM BAND
WIDTH
DELTA THETA ALPHA BETA
BASELINE 6.7"3.1 2.4" 1.8 4.5"2.4 48.2"12.6 29.0"13.5 14.5"3.5 8.2"1.9
SaO2
(0.85-0.67) 7.1" 5.0 2.9"3.4 4.9"4.2 51.8"12.0 27.6"11.9 12.7"2.0 7.7"2.1
RECOVERY 6.9"3.2 2.6"2.8 4.8"2.9 47.0"12.5 30.1"14.6 13.9"2.8 9.2"2.3
ANOVA repeated measurements showed no significant differences between the three periods. Means ± SD.
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Fig. 1.
BASELINE SaO2 0.75 – 0.85 RECOVERY
Representative example of MCM amplitude patterns in µV during baseline,
hypoxemia and recovery in a 25 1/7 weeks GA (patient no. 2). MCM amplitude
patterns remained unchanged during hypoxemia (SaO2 0.75 to 0.85).
Discussion
This study was conducted to reveal further understanding of neuronal function
under acute hypoxemic conditions in normotensive VLBWI. The data showed that
those infants maintained an unchanged electrical brain activity under isolated acute
short mild to moderate hypoxemia. We primarily expected a decrease of aEEG
amplitude and a shift of the power spectrum to lower frequencies in response to the
hypoxemic insult. However, neither aEEG amplitude nor spectral power were
influenced by hypoxemia. In this manner, the present data open several points of
discussion.
The traditional multichannel EEG registration enables detection of electrical brain
activity abnormalities, which are strictly linked to abnormal cerebral metabolism,
haemodynamics or oxygenation. These abnormalities may remain clinically
unrecognized because of sedation, muscle paralysis or electro-clinical dissociation
in case of seizure activity in newborn infants. EEG monitoring depicts actual
neuronal function and therefore enables early identification of abnormalities. This
might be crucial in the neonatal intensive care because of the increased number of
survivors with permanent neurological sequel (4). Based on the well established
diagnostic and prognostic value of background full-term neonatal EEG activity (20),
the classical single-channel aEEG called CFM has been validated and has
emerged as a reliable diagnostic tool (1,7). Clinical neonatal studies using CFM
mainly focussed on the recognition of abnormal patterns in term infants, e.g.,
isoelectric or burst-suppression patterns. These studies showed that single-channel
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aEEG abnormal patterns are strongly associated with permanent neurologic deficit
(6,10). However, neonatal intensive care deals not only with full-term asphyctic
infants, but essentially with extremely preterm infants. The analysis of the latter is
more complex because age-appropriate maturational EEG and aEEG patterns of
extreme preterm infants are not yet well studied, and information about abnormal
aEEG patterns of discontinuous physiological background EEG is exceptional.
There have been a number of studies in recent years attempting to define a
normal reference range of background characteristics using early (< 24 h of age)
multichannel EEG in extreme preterm infants. Biagioni et al. (5) presented the so-
called occipital sawtooth as a physiological EEG pattern characteristic of preterm
infants between 24-26 weeks GA. Selton et al. (26) described EEG patterns of
normal preterm infants between 26 and 28 weeks GA and Hayakawa et al. (14)
showed the characteristics of the normal background EEG in newborns from 21
weeks through 26 weeks of gestation. Those patterns are basically
interhemispherically synchronous and the percentage of discontinuous EEG activity
correlates inversely with GA. In contrast, little has been reported regarding aEEG in
VLBWI. Early short-term single-channel aEEG in VLBWI has been used to
characterize changes in EEG background activity after perinatal asphyxia (3) and
during the administration of surfactant (22). In addition, early long-term (continuos)
single channel aEEG has been applied in VLBWI to detect subclinical seizures (15),
to estimate outcome in infants with or without perinatal HIE (7,16), to evaluate EEG
changes during surfactant treatment (17) and to monitor the effect of anticonvulsant
drugs (18). This is the first study to report measurements of electrical brain activity
changes in normal preterm brain during hypoxemia registered by early long-term
aEEG.
With the development of the three-channel Maastricht cerebral monitor (MCM)
(24), we were able to disclose information not available from visual assessment of
the classical one-channel aEEG paper tracing e.g., the on-and off-line display of
original raw EEG and its frequency spectra. In addition, MCM enabled on-and off-
line signal analysis of aEEG amplitude and relative spectral power.
All our mechanically ventilated patients required continuous infusion of fentanyl as
routine clinical management at 1 to 2 µg/kg/hr (25). No protective effect to the
preterm brain was expected using that low maintenance dose.
In this study, normotensive normal preterm brain preserved unchanged electrical
brain activity under isolated mild to moderate acute hypoxemia. The lack of change
in EEG parameters opens interesting points of debate, with respect to the
hypoxemic insult and its adaptation, and secondly, to the neuronal tolerance to
hypoxemia.
1. Hypoxemia
The most appropriate SaO2 reference range in newborns is a controversial item
(23). In clinical practice, a Pa O2 around 5.0 kPa could be considered the lower
edge of normoxia in preterm infants. This level of oxygen tension is considered
appropriate because it is sufficient in fetal life, it assures a normal acid-base
balance neonatally and it lies far above the level at which cyanosis becomes
clinically evident. Wasunna et al. (29) showed that this oxygen tension level
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corresponds to a SaO2 of 0.86 in preterm infants. Therefore, our ward protocols aim
to keep SaO2 between the target range of 0.86 to 0.93. Hypoxic hypoxemia defined
as a SaO2 of < 0.85 in mechanically ventilated infants (8) is related to
intrapulmonary and extrapulmonary shunting, e.g., alveolar hypoventilation due to
active expiration events, tube obstruction or dislocation. During the hypoxemic
event, neuronal oxygen consumption is initially met by an increased oxygen delivery
(DO2) through increased cardiac output and centralization of blood flow. Another
compensatory mechanism to maintain oxygen consumption is to increase oxygen
extraction (VO2) with a reduction of the venous oxygen content (19). Oxygen
restricted metabolism takes place when compensatory mechanisms fail and both
DO2 and VO2 decline below a critical level. The lack of EBA changes from
hypoxemia in our patients may be explained by the adequacy of these
compensatory mechanisms at this SaO2 level.
2. Neuronal tolerance
It is a clinical fact that chronic lower oxygen conditions can be well tolerated by
infants of any gestational age if systemic haemodynamic and metabolic conditions
are stable, e.g., infants with cyanotic cardiopathies. Neurodevelopmental studies
have confirmed this clinical statement. Graziani et al. (13) showed that hypoxemia
without systemic hypotension prior to or during neonatal extracorporal membrane
oxygenation in (near) term newborn infants did not contribute to any neurologic or
audiologic sequel at 15 months of age of older. Recently, evidence showed that
preterm infants of less than 28 weeks gestation managed in a lower saturation
range (SaO2 0.70 to 0.90) developed significant less retinopathy of prematurity, less
respiratory support and better growth than their counterparts nursed in a richer
oxygen environment (SaO2 0.88 to 0.98). Both groups of preterm infants exhibit
identical incidence of cerebral palsy and survival rate at one year corrected age
(27).
What is the critical level of inappropriate cellular oxygen delivery and secondary
disrupted cerebral metabolism linked with long-term poor neurodevelopment?
Oxygen therapy harms pulmonary, retinal and eventually brain cells. Do we overtreat
when targeting SaO2 of > 0.86 in the tiny preterm infant? Our study doesn’t answer
these questions, rather it opens them and shows that neuronal electrical activity and
consequently neuronal oxygen metabolism were preserved during short-term
isolated acute hypoxemia. These findings, however, might be only applicable to the
intact preterm brain.
Altogether, the present data support the concept that the lower limit of normoxia
used in clinical medicine (SaO2 of 0.86) is significantly higher than the neuronal
hypoxic threshold in the non-encephalopatic preterm brain. Additional
(electrophysiological) studies are needed regarding the eventual implementation of
a more restrictive oxygen supply policy in preterm infants.
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9.1. General discussion
Extensive EEG data, since Berger’s first report in 1929, supports the evidence
that electrical brain activity (EBA) reflects the maturity and integrity of the
central nervous system and that EEG is a unique diagnostic tool for epilepsy. In
regards to its prognostic use, neonatal background EEG maturational activity
correlates with outcome. The more severe the EEG abnormality, the more
impaired the outcome. However, predicting outcome based on a single EEG
registration is discouraged (Holmes and Lombroso, 1993). In addition, serial
neonatal EEGs alone are better predictors of neurological outcome than brain
imaging or clinical neonatal evaluation (Tharp et al., 1989; Biagioni et al.,
1996).
EBA monitoring in the neonatal intensive care however, is not implemented
because of the classical EEG difficulties, such as the necessary expertise for its
interpretation. The net result has been that the on-line continuous neonatal
monitoring of physiologic variables does not include electrical brain activity. In
this context, an important first step toward EBA monitoring has been the
introduction of the cerebral function monitor (CFM) or amplitude integrated
EEG (aEEG) based on pattern recognition. Clinical data on the assessment of
EBA by CFM have been extensively reported since 1969 (Maynard et al.). The
most relevant neonatal data are concerned with the neurological outcome of
postasphyctic full-term infant. To the contrary, the present work focuses on the
on-line preterm EBA monitoring and on experimental fetal and neonatal EBA
data.
Impaired oxygenation, or the imbalance between oxygen supply and demand,
may induce substantial systemic and neuronal effects and remains prevalent in
neonatal intensive care. Therefore, this work has focused on animal
experimentation of on-line monitoring of electrocortical brain activity in the fetal
sheep and the neonatal piglet and in very low birth weight infants (VLBWI:
<1500 g birth weight) subjected to experimental or clinical hypoxemia, systemic
hypotension or a combination of the two. Based on biochemical (Johnston,
2001) and hemodynamic data (Johnston et al., 2001), we hypothesized that
isolated or superimposed systemic hypotension should strongly impair cerebral
perfusion and subsequently EBA when compared with hypoxemia alone.
Furthermore, we expected a significant increase in the slow delta (δ) EEG
spectral power during hypoxemia and/or hypotension as an early marker of
declined electrical brain function.
We further aimed to develop a quantitative aEEG monitor, which extracts
parameters of three-EEG raw signals, to simplify, quantify and analyze EBA.
The developed system is further called the Maastricht cerebral monitor (MCM,
chapter 3).
9.2. Main results
The Maastricht Cerebral Monitor provides advanced signal analysis in the
amplitude and frequency domains. It was developed with a software system
called Poly (Inspektor Research System, Amsterdam, NL) for acquisition, high
quality real-time display and on-/off-line EEG analysis.
125
Severe hypoxemia and/or hypotension were induced in the fetal sheep and
newborn piglet in order to study neuronal thresholds of dysfunction and to test
the MCM. MCM data collected from fetal and neonatal animal experimentation
illustrated several findings:
First, repetitive umbilical cord occlusions for 2 out of 5 minutes in the fetal
sheep (60% of full-term gestation; chapter 4) showed that aEEG amplitude but
not EEG spectral power analysis had already decreased during the first
normotensive cord occlusion. In other words, aEEG amplitude decreased
before the onset of significant hypotension, which follows at the end of the
occlusion period. Further, brain histological examination showed no damage.
Secondly, acute moderate or severe hypoxemia (SaO2 67± 13.4% and 28.4 ±
9.3%, respectively) caused no change in aEEG amplitude in newborn piglets
(chapter 5). Further, no differences in aEEG or haemodynamic parameters were
observed as compared to baseline registration during isolated moderate
hypotension (MAP 59.3 ± 7.8 mmHg). However, aEEG amplitude decreased
significantly during severe systemic hypotension (MAP 35.1 ±13.5 mmHg) and
during combined moderate hypotension with hypoxemia (SaO2 < 85% and MAP
<75 mmHg).
Further, we studied cerebral hemodynamics and oxygenation in the one-week
old piglet. The experimental protocol used here combined for the first time
NIRS and aEEG in the study of nonacidotic, normocarbic, normoxemic
systemic hypotension (chapter 6) and normotensive graded hypoxemia
(chapter 7) in order to correlate intracellular oxygenation and cerebral
hemodynamics with electrocortical function.
During normoxemic hemorrhagic hypotension (chapter 6), MCM amplitude
remained stable until the MAP, carotid blood flow (Qcar) and oxy- +
deoxyhaemoglobin (tHb) dropped below 30 mmHg (41% of baseline), 20
ml/min (33% of baseline) and 82 % of baseline respectively. δwave frequency
percentage increased throughout the experiment and significantly at MAP
below 30 mmHg. aEEG amplitude remained depressed after blood reinfusion
and haemodynamic recovery. Cytaa3 changes were not statistically significant,
reflecting sufficient neuronal oxygenation.
During two episodes of normotensive graded hypoxemia (chapter 7), δ EEG
power increased significantly and the aEEG amplitude dropped below 10 and 5
µvolts at the end of the first and the second hypoxemic period [PaO2 2.68±1,08
(p<0.05) and 2.87±0.58 kPa, respectively]. Both aEEG variables normalized
during recovery (FiO2 0.21). Qcar , CBV and Cytaa3 were not changed. A
decreasing MAP however, was seen throughout the experiment (episode a:
MAP baseline 83.5 ± 17.6 mmHg decreased to 58.7± 17.0 mmHg at FiO2 0.05;
episode b: MAP baseline of 74.5 ± 4.3 mmHg decreased to 47.8 ± 13.8 mmHg
at FiO2 0.05). The following data supports the notion that this level of systemic
blood pressure throughout graded hypoxemia assured an appropriate cerebral
perfusion: a) Qcar remained unaltered over the hypoxemic phases. b) As shown
in chapter 6, aEEG became impaired when both MAP and Qcar declined below
18.2 ± 7.8 mmHg and 9.7 ± 3.7 ml/min, respectively. c) Other authors have
shown an impaired neuronal oxygenation to occur when MAP dropped below
17 mmHg in the hypoxemic neonatal piglet (Tsuji et al., 1995).
126
Finally, based on both the above described experimental data and on the
expertise using the MCM, the later was introduced in the clinical setting. The
impact of spontaneous normotensive hypoxemia (SaO2 0.85 to 0.67) was
studied using on-line, long-term MCM in eight VLBWI (gestational age: 24 to 31
weeks; birth weight: 575-1470 g) (chapter 8). VLBWI exhibited 66 episodes of
isolated hypoxemia. MCM amplitude analysis during isolated hypoxemia,
relative spectral power, raw EEG and MCM amplitude patterns were
comparable to baseline and recovery values.
9.3. Main conclusions
According to the aforementioned experimental and clinical aEEG data using
the Maastricht Cerebral Monitor, we conclude that:
1. The developed Maastricht Cerebral Monitor is a flexible and user-friendly
system that not only overcomes the CFM drawbacks but also provides
advanced signal analysis.
2. Adaptive hemodynamic and cellular mechanisms in response to hypoxemia
and/or hypotension, offer an important buffer between normal and abnormal
aEEG activity.
3. aEEG alterations precede neuronal hypoxia.
4. aEEG changes during hypoxemia/hypotension in the fetal sheep differed
from the observations in the newborn piglet. Reductions in aEEG amplitude
occurred in response to hypoxemia earlier in the fetal sheep as compared to
the one-week old piglet. In addition, the EEG power percentage revealed no
changes in the fetal sheep, while shift towards the lower bands occurred
during both severe graded hypoxemia and severe hypotension in newborn
piglets. These data, although resulting from different animal species, may
suggest the possibility that the fetal brain is more sensitive to hypoxemia
than the newborn brain.
5. During severe isolated hypoxemia, neuronal (electrical) function is assured
through sufficient intracellular oxygenation. Cerebral perfusion is only
affected when moderate hypoxemia (SaO2 < 85%) and moderate systemic
hypotension (MAP < 75 mmHg) are associated in the newborn piglet.
6. The lower limit of normal cerebral perfusion in the normoxemic newborn
piglet is at 30 mmHg MAP, 20 ml/min Qcar and a tHb of 82 % of baseline.
7. Extreme hypoxemia (PaO2 2.68±1,08 kPa) is needed to induce EBA
dysfunction in the normotensive newborn piglet.
8. Normotensive VLBWI maintained an unchanged electrical brain activity
whilst under isolated, moderate acute hypoxemia (SaO2 0.67 to 0.85).
These data suggest that the limit of hypoxemia used in clinical medicine
(SaO2 of 0.85) is significant higher than the neuronal hypoxic threshold.
9. According to points 5, 6, 7 and 8: cerebral perfusion is more important than
oxygen delivery for the maintenance of neuronal oxygenation.
10. The evidence with respect to the EEG δ power as an early marker for brain
dysfunction is inconsistent though there is a trend toward augmentation. This
can be partly explained by the fact that the animals were under anaesthesia.
11. As previously stated, aEEG does not replace conventional multi-channel
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routine EEG in the clinical setting.
9.4. Personal considerations
I would like to communicate some thoughts on my experiences during the
production of this thesis.
I started this work, based on the fact that EEG is an excellent tool to depict
brain function, under the assumption of acute neuronal changes in response to
hypoxemia and/or hypotension in experimental models and in VLBWI. The
observations however, clearly demonstrate that neuronal damage commences
only after the failure of long-standing adaptive mechanisms. These results, far
from discouraging me, enriched my knowledge and stimulated further research
questions. In addition, the present work gave me the personal satisfaction to be
part of a multidisciplinary team working in a field that we appreciate and enjoy.
The general aim of this thesis was directed both towards the development of
a flexible aEEG system and to the study of the neonatal brain with particular
attention given to the effects of impaired oxygenation. We have fulfilled this
aim.
9.5. Implications for clinical practice and future research
From the results of the present work we think that the use of aEEG for
continuous EBA monitoring has an important place in the neonatal intensive
care. The Maastricht Cerebral Monitor is well suited for this purpose.
Sustained development however implicates, further work and new objectives:
Our current clinical research focuses on the role of normoxemic hypotension in
VLBWI and the study of early aEEG changes in the post-asphyctic VLBWI.
Further, the simultaneous storage of physiologic variables and aEEG activity by
the Maastricht Cerebral Monitor is pending and will enhance its research
application.
Finally, the use of mathematical algorithms in the automated detection of
aEEG events or abnormalities such as seizures and inappropriate background
activity is under consideration by other authors. The results of their research are
very encouraging (Gotman et al., 1997; Hellstrom-Westas L, 2002).
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9.1. Algemene discussie
Sinds het eerste verslag van Berger in 1929, is er een aanzienlijke hoeveelheid
gegevens die het bewijs ondersteunen dat elektrische hersenactiviteit een
weergave is van de ontwikkeling en de integriteit van het centraal zenuwstelsel en
dat EEG een uniek diagnostisch middel is ten aanzien van epilepsie. Wat de
prognose betreft, is er een correlatie tussen het neonatale achtergrondpatroon op
het EEG en de outcome. Hoe ernstiger de afwijkingen op het EEG, hoe slechter de
outcome. Het voorspellen van de outcome aan de hand van een enkele EEG-
registratie wordt echter afgeraden (Holmes and Lombroso, 1993). Daar tegenover
staat dat opeenvolgende neonatale EEG’s een betere voorspellende waarde
hebben dan beeldvorming van het brein of klinische evaluatie van de pasgeborene
(Tharp et al., 1989; Biagioni et al., 1996).
Het monitoren van elektrische hersenactiviteit wordt echter nog niet
geïmplementeerd in de neonatale intensieve care vanwege klassieke barrières
zoals de expertise die vereist is voor de interpretatie ervan. Het netto resultaat
hiervan is dat de elektrische hersenactiviteit geen deel uitmaakt van het continu
monitoren van fysiologische variabelen bij pasgeborenen. In deze context is de
introductie van de cerebral function monitor (CFM) of amplitude integrated EEG
(aEEG) een belangrijke eerste stap geweest. Sinds 1969 (Maynard et al.) zijn er op
grote schaal klinische gegevens gepubliceerd over meting van elektrische
hersenactiviteit met behulp van CFM. De meest relevante data wat betreft
pasgeborenen beschrijven de neurologische outcome van post-asfyctische à terme
pasgeborenen. Aan de andere kant richt dit huidige onderzoek zich op het on-line
monitoren van elektrische hersenactiviteit bij prematuren en op experimentele
foetale en neonatale EBA gegevens.
Een verminderde zuurstofvoorziening dan wel een verstoring van de balans
tussen de vraag naar en de aanvoer van zuurstof, kunnen ernstige systemische en
neuronale effecten met zich meedragen en zijn entiteiten die aanwezig blijven in de
neonatale intensive care. Om die reden richt dit werk zich op dierexperimenteel
onderzoek door middel van het online monitoren van elektrische hersenactiviteit bij
foetale lammeren en pasgeboren biggen en bij pasgeborenen met een zeer laag
geboortegewicht (very low birthweight infants, VLBWI: geboortegewicht < 1500
gram). Deze worden blootgesteld aan experimentele dan wel klinische hypoxemie
of hypotensie dan wel een combinatie van beide. Op grond van biochemische
(Johnston, 2001) en hemodynamische gegevens (Johnston et al., 2001) stelden wij
de hypothese op dat geïsoleerde dan wel gesuperponeerde systemische
hypotensie een groter negatief effect zou hebben op de cerebrale perfusie, en
daarmee de elektrische hersenactiviteit, dan hypoxemie alleen. Daarbij verwachtten
we een significante toename van de kracht van de langzame δ-golven in het EEG-
spectrum tijdens hypoxemie en/of hypotensie als een vroeg teken van een
verslechterde elektrische hersenactiviteit.
Verder hebben we ons erop gericht om een kwantitatieve aEEG te ontwikkelen die
gegevens verkrijgt via ruwe signalen van een driekanalen-EEG, om op die manier
elektrische hersenactiviteit te kunnen vereenvoudigen, te kwantificeren en te
analyseren. Deze monitor wordt verder de Maastricht Cerebral Monitor (MCM,
hoofdstuk 3) genoemd.
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9.2. Belangrijkste resultaten
De MCM geeft een geavanceerde signaal-analyse van de amplitude- en
frequentiedomeinen. Voor het verkrijgen van de gegevens en de mogelijkheden
van een hoog kwalitatieve real-time display en on/off-analyse, werd de MCM
ontwikkeld met een software-systeem Poly (Inspektor Research System,
Amsterdam, NL).
Om de drempelwaarde van neuronale disfunctie te bestuderen en de MCM te
testen, werden foetale lammeren en pasgeboren biggen blootgesteld aan ernstige
hypoxemie en/of hypotensie. Gegevens verkregen met de MCM door middel van
foetaal en neonataal dierexperimenteel onderzoek leidden tot verscheidene
bevindingen:
Ten eerste bleek dat bij herhaaldelijk afsluiten van de navelstreng bij foetale
lammeren (60% van voldragen leeftijd, hoofdstuk 4) gedurende 2 per 5 minuten,
reeds bij de eerste normotensieve periode van afsluiting de amplitude op het aEEG
een afname toonde, terwijl de EEG spectrale power-analyse onveranderd bleef.
Daarbij was histologisch onderzoek van de hersenen zonder afwijkingen.
Een tweede bevinding was, dat er geen afwijkingen te zien waren in de amplitude
van het aEEG bij pasgeboren biggen tijdens acute matige en ernstige hypoxemie
(SaO2 respectievelijk 67 ± 13,4% en 28,4 ± 9,3%) (hoofdstuk 5). Daarbij werden er
tijdens geïsoleerde matige hypotensie (MAP 59,3 ± 7,8 mmHg) geen veranderingen
gezien van de aEEG en hemodynamische parameters ten opzichte van de
baseline-registratie. Echter, tijdens ernstige systemische hypotensie (MAP 35,1 ±
13,5 mmHg) en gecombineerde matige hypotensie en hypoxemie (MAP < 75
mmHg en SaO2 < 85%) was er een significante afname van de amplitude op het
aEEG.
In een later stadium bestudeerden we de cerebrale hemodynamiek en
zuurstofvoorziening bij biggen van een week oud. Ons experimentele protocol
combineerde voor het eerst NIRS en aEEG bij het bestuderen van niet-acidotische,
normocapnische en normoxemische systemische hypotensie (hoofdstuk 6) en
normotensieve gegradeerde hypoxemie (hoofdstuk 7). Op deze manier werden
intracellulaire oxygenatie en cerebrale hemodynamiek gecorreleerd aan
electrocorticale functie.
Tijdens normoxemische hemorrhagische hypotensie bleef de amplitude op de
MCM stabiel totdat de MAP daalde tot onder de 30 mmHg (41% van de baseline-
waarde), de Qcar tot onder de 20 ml/min (33% van de baseline-waarde) en de tHb
tot onder de 82% van de baseline-waarde. Tijdens het experiment nam het
percentage δ-golf-frequentie toe en deze toename werd significant bij een MAP
onder de 30 mmHg.De amplitude op het bleef verlaagd na bloed-reinfusie en
hemodynamisch herstel. Veranderingen van het Cytaa3 waren niet statistisch
significant, wat weergeeft dat de neuronale oxygenatie toereikend bleef.
Tijdens twee periodes van normotensieve, gegradeerde hypoxemie (hoofdstuk 7)
nam de δ-kracht op het EEG significant toe en de amplitude van het aEEG af tot
respectievelijk onder de 10 en 5 µvolt aan het eind van de twee periodes van
hypoxemie (PaO2 respectievelijk 2,68 ± 1,08 (p<0,05) en 2,87 ± 0,58 kPa). Deze
beide EEG-variabelen normaliseerden gedurende de herstelfase (FiO2 21%). De
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Qcar, het CBV en het Cytaa3 bleven onveranderd. Wel werd een dalende MAP
gezien gedurende het experiment (episode a: baseline-MAP 83 ± 17,6 mmHg,
dalend tot 58,7 ± 17,0 mmHg bij een FiO2 van 5%; episode b: baseline-MAP 74,5 ±
4,3 mmHg, dalend tot 47,8 ± 13,8 mmHg bij een FiO2 van 5%). De nu volgende
gegevens ondersteunen echter de vaststelling dat door de systemische bloeddruk
een afdoende cerebrale bloedtoevoer verzekerd werd gedurende dit experiment
van gegradeerde hypoxemie: a) de Qcar bleef onveranderd tijdens de hypoxemische
periodes; b) zoals we kunnen zien in hoofdstuk 6, verslechterde het aEEG pas op
het moment dat de MAP daalde tot onder de 18,2 ± 7,8 mmHg en de Qcar tot onder
de 9,7 ± 3,7 ml/min; en c) eerdere experimenten bij hypoxemische pasgeboren
biggen lieten pas een verslechterde neuronale oxygenatie zien bij een daling van
de MAP onder de 17 mmHg (Tsuji et al., 1995).
Tenslotte, op basis van de hierboven beschreven experimentele gegevens over
het gebruik van de MCM, werd deze in de klinische setting geïntroduceerd. Bij acht
VLBWI (geboren bij zwangerschapstermijn 24-31 weken; geboortegewicht 575-
1470 gram) werd de invloed van spontane, normotensieve hypoxemie (SaO2 67-
85%) geëvalueerd met behulp van langdurige on-line monitoring met de MCM
(hoofdstuk 8). Deze VLBWI hadden totaal 66 episodes van geïsoleerde hypoxemie.
De uitkomsten van amplitude-analyse van de MCM, de relatieve spectrale kracht,
het ruwe EEG en de amplitudepatronen op de MCM tijdens de geïsoleerde
hypoxemie waren vergelijkbaar met de baseline-waarden en de waarden tijdens de
herstelfase.
9.3. Belangrijkste conclusies
Naar aanleiding van de hierboven besproken experimentele en klinische aEEG-
gegevens verkregen via de MCM, kunnen we de volgende conclusies trekken:
1. De ontwikkelde MCM is een flexibel en gebruiksvriendelijk systeem dat niet
alleen de nadelen van de CFM overwint, maar ook een geavanceerde signaal-
analyse mogelijk maakt.
2. Hemodynamische en cellulaire aanpassingsmechanismen als reactie op
hypoxemie en/of hypotensie vormen een belangrijke buffer tussen normale en
afwijkende activiteit op het aEEG.
3. Veranderingen in het aEEG gaan vooraf aan neuronale hypoxie.
4. De veranderingen in het aEEG verschillen tussen foetale lammeren en
pasgeboren biggen. In vergelijking met pasgeboren biggen treedt er bij foetale
lammeren eerder een afname van de amplitude op het aEEG op. Daarbij traden er
geen veranderingen in het spectrale power van het EEG op bij de foetale
lammeren, terwijl er bij de pasgeboren biggen een verschuiving optrad richting de
lagere banden tijdens zowel ernstige gegradeerde hypoxemie als ernstige
hypotensie. Hoewel deze gegevens verkregen zijn bij verschillende diersoorten,
suggereren ze dat het foetale brein gevoeliger is voor hypoxemie dan het brein van
de pasgeborene.
5. Tijdens ernstige geïsoleerde hypoxemie wordt de neuronale (elektrische) functie
verzekerd door een afdoende intracellulaire oxygenatie. Bij pasgeboren biggen is
de cerebrale perfusie aangedaan wanneer matige systemische hypotensie (MAP <
75 mmHg) samengaat met matige hypoxemie (SaO2 < 85%).
6. De ondergrens van een normale cerebrale perfusie bij de normoxemische
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pasgeboren biggen is veilig gesteld bij een MAP van 30 mmHg, een Qcar van 20
ml/min en een tHb op 82% van de baseline-waarde.
7. Er is een extreme hypoxemie (PaO2 2,86 ± 1,08 kPa) nodig om bij pasgeboren
biggen afwijkingen op het aEEG te bewerkstelligen.
8. Normotensieve VLBWI toonden een onveranderde elektrische hersenactiviteit
gedurende acute, matige, geïsoleerde hypoxemie (SaO2 67-85%). Dit suggereert
dat de grens van hypoxemie zoals die wordt gehanteerd in de klinische setting
(SaO2 85%) significant hoger is dan de drempelwaarde voor neuronale hypoxie.
9. Uit de punten 5 t/m 8 kan worden afgeleid dat de mate van cerebrale perfusie
belangrijker is voor het behoud van een goede intraneuronale oxygenatie dan de
zuurstof content.
10. Aanwijzingen voor de bruikbaarheid van EEG δ-power als een vroege marker
voor disfunctie van het brein zijn niet consistent, hoewel er een neiging is tot een
toename ervan. Dit gebrek aan consistentie kan deels verklaard worden door het
feit dat de dieren onder anesthesie waren.
11. Zoals reeds eerder gesteld kan het aEEG geen vervanging zijn van het routine
multichannel-EEG in de klinische setting.
9.4. Persoonlijke overwegingen
Graag zou ik enkele gedachten uitwerken met betrekking tot de ervaringen zoals
ik die heb opgedaan tijdens het proces van dit proefschrift.
Ik ben dit werk begonnen gebaseerd op het feit dat het EEG een uitstekend
instrument is om hersenactiviteit in beeld te brengen en met de aanname dat er
acute neuronale veranderingen zouden optreden als reactie op hypoxemie en/of
hypotensie in experimentele modellen en bij VLBWI. De bevindingen van dit
onderzoek tonen echter duidelijk dat neuronale schade pas optreedt na falen van
langdurige aanpassingsmechanismen. In tegenstelling tot dat deze resultaten mij
ontmoedigden, waren ze een verrijking voor mijn kennis en stimuleerden me tot het
ontwikkelen van verdere onderzoeksvragen. Daarbij gaf het huidige werk me de
persoonlijke voldoening om deel uit te maken van een multidisciplinair team dat
werkt in een onderzoeksveld dat ze waardeert en waarvan ze geniet.
Het algemene doel van dit proefschrift was zowel het ontwikkelen van een flexibel
aEEG-systeem als het bestuderen van het neonatale brein, met speciale aandacht
voor de effecten van een verminderde oxygenatie hierop. Dit doel hebben we
bereikt.
9.5. Implicaties voor de praktijk en toekomstige onderzoeken
Vanuit de resultaten van ons huidige onderzoek denken we dat het gebruik van
het aEEG als een continue monitoring van elektrische hersenactiviteit een plek
heeft in de huidige neonatale intensive care. De MCM is zeer geschikt voor dit doel.
Een aanhoudende ontwikkeling impliceert echter aanhoudend onderzoek en
nieuwe doelen: ons huidige onderzoek richt zich op de rol van normoxemische
hypotensie in VLBWI en op het bestuderen van vroege veranderingen op het aEEG
bij post-asfyctische VLBWI. Daarnaast wordt er gewerkt aan een gelijktijdige opslag
van fysiologische variabelen en aEEG-activiteit met de MCM, iets dat ook de
mogelijkheden voor toepassing ten behoeve van onderzoek zal vergroten.
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Tenslotte wordt er door verscheidene auteurs nagedacht over het gebruik van
wiskundige algoritmes voor een geautomatiseerde detectie van gebeurtenissen op
het aEEG en afwijkingen zoals epileptische aanvallen en een afwijkend
achtergrondpatroon. De resultaten van die onderzoeken zijn zeer aanmoedigend
(Gotman et al., 1997; Hellstrom-Westas L, 2002).
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9.1. Discusión general
Desde el primer reporte de Berger en 1929, un volumen importante de datos
apoyan el hecho que la actividad eléctrica cerebral (AEC) refleja la madurez e
integridad del sistema nervioso central y que el EEG es un medio de diagnóstico
único en la epilepsia. En lo que respecta al valor pronóstico del EEG, existe una
correlación entre la actividad de base del EEG neonatal con las consecuencias
clínicas a largo plazo. Mientras más severa la anomalía del EEG más importantes
serán estas consecuencias. Sin embargo, predicciones clínicas en base a un solo
EEG son poco recomendables (Holmes and Lombroso, 1993). Adicionalmente,
EEG’s neonatales sucesivos podrían tener un mayor valor predictivo de patología
neurológica que el diagnóstico de imagen cerebral o que la evaluación clínica
neonatal (Tharp et al., 1989; Biagioni et al., 1996).
A pesar de su importancia, el monitoreo de la actividad eléctrica cerebral no está
implementado en los cuidados intensivos neonatales debido a las clásicas
dificultades de interpretación del EEG. El resultado neto es que el monitoreo
continuo de variables fisiológicas del neonato no incluyen a la actividad eléctrica
cerebral. En este contexto, la introducción del monitor de función cerebral (MFC) o
EEG de amplitud integrada (aEEG) basado en reconocimientos de patrones ha
constituido el primer paso hacia el monitoreo de la AEC neonatal. Información
clínica basada en el monitoreo del AEC por medio del MFC ha sido extensivamente
reportada desde 1969 (Maynard et al.). La información neonatal más relevante
concierne a las consecuencias neurológicas de recién nacidos post-asfícticos a
término. Al contrario, este trabajo se centra en el monitoreo en línea de la AEC del
paciente pretérmino y en la investigación de la AEC experimental fetal y neonatal.
Trastornos de oxigenación, o el inbalance entre abastecimiento y demanda de
oxígeno, son entidades que prevalecen en los cuidados intensivos neonatales y
que pueden inducir importantes efectos sistémicos y neuronales. Por este motivo el
presente trabajo se ha enfocado en la experimentación animal del monitoreo en
línea de la AEC del feto del cordero y de cerdos recién nacidos, así como de recién
nacidos con muy bajo peso al nacer (very low birthweight infants, VLBWI: peso al
nacer < 1500 gr). Estos han sido sujetos a hipoxemia experimental o clínica,
hipotensión sistémica o a ambas. Basándonos en información bioquímica
(Johnston, 2001) y hemodinámica (Johnston, et al., 2001), nos planteamos la
hipótesis que la hipotensión sistémica aislada o la superimpuesta a la hipoxia
debería tener un efecto negativo mas importante en la perfusión cerebral y por
consiguiente en la AEC, que la hipoxia aislada. Además, esperabamos un
incremento importante de la frecuencia delta (δ) del EEG durante la hypoxemia y/o
hipotensión, como un marcador temprano de deterioro de la actividad eléctrica
cerebral. Adicionalmente, nos propusimos desarrollar un monitor aEEG cuantitativo
que extrayera parámetros de 3 señales crudas de EEG, para simplificar, cuantificar
y analizar la AEC. El sistema desarrollado ser nombrado en lo sucesivo Monitor
Cerebral Maastricht (MCM, capítulo 3).
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9.2. Resultados principales
MCM provee un análisis avanzado en los dominios de amplitud y frecuencia del
EEG. Se desarrollo utilizando el sistema programa de computación Poly (Inspektor
Research System, Amsterdam, NL), para la adquisición, proyección en tiempo real
y análisis de EEG en-o fuera de línea.
Hipoxemia severa y/o hipotensión fueron inducidas en el feto de cordero y en el
cerdo recién nacido, con el fin de estudiar los límites de disfunción neuronal y
además para probar el sistema MCM. Los datos de investigación arrojan los
siguientes resultados:
1. Oclusiones repetitivas del cordón umbilical durante 2 de cada 5 minutos en el
feto del cordero (60% de gestación completa; capítulo 4), deprimen
immediatamente la amplitud del aEEG, sin afectar jamás las bandas de
frecuencias del EEG. Además, el examen histológico cerebral no presentó daño
alguno.
2. Periodos agudos de hipoxia moderada o severa (SaO2 67± 13.4% and 28.4 ±
9.3, respectivamente) no afectan la amplitud del aEEG en cerdos recién
nacidos (capitulo 5). Además, no se presentaron cambios hemodinámicos ni de
aEEG durante la hipotensión moderada (MAP 59.3 ± 7.8 mmHg). Sin embargo,
la amplitud del aEEG decreció significativamente durante la hipotensión
sistémica severa (MAP 35.1 ±13.5 mmHg) y durante la combinación de
hipotensión moderada e hipoxemia (SaO2 < 85% y MAP <75 mmHg).
3. La hipotensión hemorrágica durante normoxemia (capitulo 6) induce una
depresión de la amplitud del aEEG cuando la presión media arterial (MAP), flujo
sanguineo carotideo (Qcar) y la oxy- + deoxyhemoglobina (tHb) dsminuyeron a
niveles inferiores a 30 mmHg (41% de linea de base), 20 ml/min (33% de la
línea de base) y 82 % de la línea de base, respectivamente. El porcentaje de la
frequencia δ se incremento a lo largo de todo el experimento, pero adquirió
significancia cuando la MAP se situó por debajo de 30 mmHg. La amplitud del
aEEG se mantuvo deprimida a pesar de la reinfusión de sangre y de la
recuperación hemodinámica. Cambios del Cytaa3 no fueron estadísticamente
significativos, reflejando una oxigenación neuronal adequada.
4. Dos periodos de hipoxemia gradual durante normotensión (chapter 7)
demostraron un incremento de la banda δ del EEG y la caída de la amplitud del
aEEG por debajo de los 10 y 5 µvolts al final de ambos periodos hipoxémicos
[PaO2 2.68±1,08 (p<0.05) y 2.87±0.58 kPa, respectivamente]. Ambas variables
del EEG se normalizaron durante el periodo de recuperación (FiO2 0.21). Qcar ,
CBV y Cytaa3 no presentaron cambios. La MAP tendió a bajar durante todo el
experimento sin alcanzar importancia estadística (episodio a: MAP línea de
base 83.5 ± 17.6 mmHg decreció a 58.7± 17.0 mmHg con una FiO2 0.05;
episodio b: MAP línea de base 74.5 ± 4.3 mmHg decrecióó a 47.8 ± 13.8 mmHg
con una FiO2 0.05). A pesar de esto, los siguientes datos apoyan la noción que
la presión sanguinea sistémica aseguró una adecuada perfusión cerebral en
este ultimo experimento: a) Qcar fue constante durante las dos fases
hypoxémicas. b) En el experimento descrito en el capítulo 6 demostramos que
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la amplitud del aEEG es afectada cuando la MAP y el Qcar se situan por debajo
de 18.2 ± 7.8 mmHg y 9.7 ± 3.7 ml/min, respectivamente. c) Otros autores han
demostrado que la oxigenación neuronal se afecta en el cerdo recien nacido
cuando la MAP disminuye por debajo de los 17 mmHg (Tsuji et al., 1995).
5. Finalmente, el MCM fue aplicado en el estudio de la actividad eléctrica cerebral
del recién nacido de muy bajo peso al nacer (< 1500 gr) sujeto a hypoxemia
normotensiva aguda moderada (SaO2 0.85 to 0.67). Se registraron 8
prematuros (edad gestacional: 24 a 31 semanas; peso al nacer: 575-1470 g)
con MCM en linea y a largo plazo (chapter 8). aEEG y EEG no manifestaron
cambios.
9.3. Conclusiones principales
1. El MCM es un sistema flexible y de uso fácil que no solamente supera la
dificultades de uso del CFM, sino que también incluye análisis avanzados de
la señal de EEG.
2. Los mecanismos hemodinámicos y celulares en respuesta a la hipoxemia y /o
hipotensión, aseguran un margen de adaptación importante.
3. Alteraciones del aEEG preceden a la hipoxia neuronal.
4. Cambios del aEEG durante hipoxemia/hipotensión en el feto del cordero
difieren de las observaciones hechas en el cerdo recién nacido. La reducción
de la amplitud del aEEG en respuesta a la hipoxemia es inmediata en el feto
del cordero. Ademas, el porcentaje de frecuencia del EEG se mantiene
inalterado en el feto del cordero, mientras que frecuencias mas lentas son
reproducidas en el cerdo recien nacido durante hipoxemia gradual grave e
hipotensión severa. Estos datos, aunque de dos especies de animales
diferentes, sugieren la posibilidad de que el cerebro fetal sea mas sensible a la
hipoxemia que el neonatal.
5. La función eléctrica neuronal esta asegurada por una oxigenación intracelular
adecuada durante la hipoxemia aislada en el cerdo recién nacido. La
perfusión cerebral se afecta únicamente cuando la hipoxemia moderada
(SaO2< 85%) esta asociada con hipotensión sistémica moderada (MAP <
75mmHg).
6. El límite de la normalidad de la perfusión cerebral en el cerdo recién nacido
normoxémico se ubica a una MAP de 30 mmHg, Qcar de 20 ml/min y tHb op
82%.
7. Se necesita una hipoxemia extrema (PaO2 2,86 ± 1,08) para inducir disfunción
electrica cerebral en el cerdo recien nacido normotensivo.
8. Prematuros de muy bajo peso al nacer mantienen una actividad eléctrica
cerebral inalterada durante la hipoxemia moderada aislada (SaO2 67-85%).
Esto sugeriría que el límite de saturación de oxígeno de 86% aceptado en la
clínica es significativamente mas alto que aquel que corresponde al umbral de
la hipoxia neuronal.
9. De acuerdo a los puntos 5,6,7 y 8 : la perfusión cerebral es mas importante
que el contenido de oxígeno sanguíneo para el mantenimiento de la función
neuronal.
10. La evidencia con respecto a la frecuencia delta del EEG como un marcador
temprano de disfunción cerebral es inconsistente en nuestros ecxperimentos.
139
El hecho de que los animales estaban bajo la influencia de anestésicos, podría
explicar en parte este hecho.
11. El aEEG no reemplaza al EEG convencional.
9.4. Implicaciones para la práctica clínica y líneas de investigación
Al presente, nuestro trabajo de investigación clínica se centra en el rol de la
hipotensión aislada en la actividad elèctrica cerebral de prematuros con muy bajo
peso al nacer y en los cambios tempranos en el aEEG inducidos por la asfixia del
recién nacido pretèrmino. Adicionalmente, esperamos incluir e a corto plazo el
registro simultaneo de variabes fisiológicas junto con el del aEEG. Esto mejorará la
aplicación del MCM en la clínica y en el laboratorio.
Finalmente cabe anotar que el uso de algorrítmos matemáticos de detección
automática de eventos, tales como convulsiones o ritmos de base abnormales,
están siendo considerados por otros autores (Gotman et al., 1997; Hellstrom-
Westas L, 2002).
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